[go: up one dir, main page]

WO2019158736A1 - Anti-stress composition - Google Patents

Anti-stress composition Download PDF

Info

Publication number
WO2019158736A1
WO2019158736A1 PCT/EP2019/053899 EP2019053899W WO2019158736A1 WO 2019158736 A1 WO2019158736 A1 WO 2019158736A1 EP 2019053899 W EP2019053899 W EP 2019053899W WO 2019158736 A1 WO2019158736 A1 WO 2019158736A1
Authority
WO
WIPO (PCT)
Prior art keywords
composition
betaine
hydrogenated
lipids
temperature
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2019/053899
Other languages
French (fr)
Inventor
Stephanie Klein
Julie CASTIER
Michel Magnin
Nicolas BREVAULT
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mixscience SAS
Original Assignee
Mixscience SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mixscience SAS filed Critical Mixscience SAS
Priority to EP19706935.4A priority Critical patent/EP3752010A1/en
Publication of WO2019158736A1 publication Critical patent/WO2019158736A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23DEDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00Other edible oils or fats, e.g. shortenings or cooking oils
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K10/00Animal feeding-stuffs
    • A23K10/30Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/158Fatty acids; Fats; Products containing oils or fats
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/174Vitamins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/10Feeding-stuffs specially adapted for particular animals for ruminants
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/20Feeding-stuffs specially adapted for particular animals for horses
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/30Feeding-stuffs specially adapted for particular animals for swines
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/70Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75Feeding-stuffs specially adapted for particular animals for birds for poultry
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11CFATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
    • C11C3/00Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
    • C11C3/12Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by hydrogenation
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Definitions

  • the invention relates to a composition that contributes to reducing the effects of non-optimal conditions, particularly against the effects of stress in animals.
  • Adaptation in breeding describes the ability of an animal to cope with the constraints of the environment, by mobilizing its main physiological functions.
  • the objective of the adaptive process for the animal is to maintain its well-being and to guarantee its survival (homeostasis) and that of its offspring (homeorhesis).
  • the thermal stress appears from the moment when the ambient temperature exceeds the zone of least effort of thermoregulation or zone of thermoneutrality.
  • Thermal stress is a problem that occurs as a result of a sudden and occasional rise in temperature (heat stroke, heat wave), or a prolonged rise in temperatures over a longer period (summer, tropical climate).
  • the animal is no longer able to regulate its body temperature, which leads to significant performance losses in breeding and therefore economic losses.
  • the equipment of livestock buildings is not always enough to avoid this situation.
  • Heat stress can be defined as the sum of forces external to a warm-blooded animal (that is, an animal that maintains a constant body temperature independently of the external environment), which act to alter its body temperature relative to the temperature of the body. normal state.
  • a composition described in patent FR3017778 B1 consisting of an extract of Scutellaria is known in particular. Baicalensis .
  • This composition is prepared from a complex of natural active ingredients, selected for their synergistic effect, and in particular Baalkaline.
  • compositions aimed at limiting or combating the effects of heat stress are still under study.
  • the invention therefore aims to overcome these shortcomings of the prior art.
  • One of the objectives of the invention is to provide a composition easy to use, easy to produce, and comprising natural compounds effective thermal stress and its physiological effects.
  • Another object of the invention is to provide a method of manufacturing such a composition.
  • the invention relates to a composition
  • a composition comprising an active substance dispersed in a matrix, said active substance comprising or consisting essentially of a mixture of betaine and an antioxidant agent, said antioxidant agent being ascorbic acid, said matrix being a matrix crystalline essentially consisting of one or more hydrogenated lipids, especially hydrogenated oil.
  • the invention is based on the unexpected finding made by the inventors that a composition comprising betaine and an antioxidant such as vitamin C (ascorbic acid), in vectorized form in a crystalline matrix has very good effects on heat stress and its consequences.
  • an antioxidant such as vitamin C (ascorbic acid)
  • composition according to the invention acts by synergy of the active compounds (betaine and antioxidant, in particular ascorbic acid or vitamin C), and promotes the resistance of monogastric animals raised to heat stress, supports the natural defenses of said animals and improves zootechnical performance.
  • active compounds betaine and antioxidant, in particular ascorbic acid or vitamin C
  • composition of the invention comprises betaine which is a substance of formula (CH 3 ) 3 N + CCOO - , available in liquid or crystalline form.
  • Anhydrous betaine of natural origin is extracted from the molasse or vinasse plants and roots thereof, mainly beet ( Beta vulgaris ), especially derived from the manufacture of sugar or bioethanol. Betaine is separated and purified by chromatography, with or without an organic solvent (of the methanol, dichloromethane or chloroform type), in the liquid phase or in the solid phase.
  • the anhydrous betaines are in solid or liquid form. Solid anhydrous betaines have a purity level ranging from 91 to 97%.
  • Synthetic betaine is obtained from chloroacetic acid and sodium carbonate, to which trimethylamine is added.
  • the synthetic betaines are in solid or liquid form.
  • Betaine HCl or hydrochloride addition of hydrochloride acid after a concentration step of the mixture of chloroacetic acid and sodium carbonate
  • the solid HCl synthetic betaines generally have a degree of purity of between 93 and 98%, the solid monohydrates have a purity of around 91% and solid anhydrates a purity of around 96%.
  • Liquid betaines have a lower purity level of between 38 and 47%.
  • Betaine plays an osmoregulatory role.
  • the protection of the intestinal epithelium against osmotic changes promotes the absorption of nutrients and thus improves zootechnical performance.
  • the maintenance of osmotic pressure protects the cells from dehydration, which is favorable to their normal metabolic functioning. An improvement in yields with betaine intake is regularly observed in the literature, and could be related to better water retention of the cells.
  • composition according to the invention also contains at least one antioxidant which is ascorbic acid (oxo-3-gulofuranolactone acid or vitamin C), which is well known to those skilled in the art.
  • antioxidant which is ascorbic acid (oxo-3-gulofuranolactone acid or vitamin C), which is well known to those skilled in the art.
  • composition according to the invention is characterized in that the betaine and the antioxidant are dispersed homogeneously in a crystalline matrix consisting essentially of one or more hydrogenated lipids.
  • the term "one or more lipids” is understood to mean a lipid mixture comprising a single type of lipid or a mixture of several types of lipids of different natures (and therefore of different chemical structures). Therefore, throughout the foregoing and following description, the terms “one or more lipids” may be uniformly replaced by the terms "a mixture of one type or a mixture of several different types of lipids”.
  • the lipids are advantageously one or more hydrogenated lipids, in particular hydrogenated oil, or hydogenated oil derivatives, such as hydrogenated fatty acids or hydrogenated fatty alcohols, the latter being able to be in free form or in the form of hydrogenated of monoglycerol, di or polyglycerol fatty acid esters.
  • this matrix is essentially composed of one or more hydrogenated lipids, in particular hydrogenated oil, or derivatives of hydogenated oil, such as acids. hydrogenated fats or hydrogenated fatty alcohols, the latter being in free form or in the form of monoglycerol, di or polyglycerol fatty acid esters
  • the lipids constituting said crystalline matrix are the lipids of an oil, especially a vegetable or animal oil.
  • oils envisaged are in particular the following:
  • vegetable oils such as rapeseed oil, oleic rapeseed oil, sunflower oil, oleic sunflower oil, coconut oil, palm oil, palm kernel oil, olive oil, peanut oil, soybean oil, corn oil, mustard oil, castor oil, palm olein, palm stearin, oil Safflower, sesame oil, linseed oil, walnut oil, grape seed oil, hemp oil,
  • animal oils and fats such as fish oils, especially fatty fish,
  • microbial oils derived from so-called oleaginous microorganisms that is to say capable of storing fatty acids containing more than 20% of their dry weight, originating from yeasts, bacteria, in particular the genus Streptomycès , or micro-algae,
  • oils comprising a mixture of fatty acids, such as esterification waters, bottoms, deodorizing condensates, washings or neutralization pastes.
  • the lipids in the invention are chosen so that the compositions which comprise them are solid, semi-solid or plastics at an ambient temperature, that is to say at a temperature of between 15 ° C. and 40 ° C., especially of 17 ° C to 30 ° C.
  • These lipids are in particular hydrogenated lipids by hydrogenation, in particular catalytic.
  • the triglycerides are treated for example in the presence of molecular hydrogen and a catalyst (in particular copper or nickel or palladium) at a temperature of 140 ° C to 250 ° C.
  • a catalyst in particular copper or nickel or palladium
  • This type of reaction is heterogeneous because there are three phases present: a gaseous phase with hydrogen, a liquid phase with the triglycerides to be hydrogenated and a solid phase with the finely divided catalyst.
  • the reaction is exothermic and evolves on the order of 100 to 150 kJ per mole of double bond.
  • the hydrogenation can be selective, it will be for example to specifically reduce the linolenic acid (C18: 3) of an oil to obtain linoleic acid (C18: 2).
  • This type of hydrogenation aims to saturate in a large proportion, or sometimes totally, the double bonds of the unsaturated fatty acids contained in the triglycerides of an oil.
  • the hydrogenated oils according to the invention are the following: refined and hydrogenated palm oil whose melting point varies from 60 to 63 ° C., hydrogenated sunflower oil whose melting point varies from 69 to 73 ° C. , refined and hydrogenated rapeseed oil having a melting point of 68 to 74 ° C and palm stearin (comprising C16-C18 fatty acids) having a melting point of 56 to 62 ° C.
  • oils of interest in the context of the invention can be used: soybean oil (non-GMO) whose melting point varies from 68 to 71 ° C or rapeseed oil (erucic high), saturated fatty acids from C12 or C14, and whose melting point ranges from 61 to 66 ° C.
  • composition according to the invention it is also possible to mix lipids according to the invention having a high melting point, at above 55 ° C., with lipids according to the invention whose melting point is below 55 ° C. In this case, it must be ensured that the melting point of the mixture will be above 55 ° C.
  • the invention relates to the abovementioned composition, in which the ascorbic acid represents from 2.5% to 8% by weight relative to the total mass of the composition.
  • the ascorbic acid contained in the composition represents, by weight relative to the total mass of the composition, 2.5%, 2.6%, 2.7%, 2.8%, 2.9%, 3%, 3.1%, 3.2%, 3.3%, 3.4%, 3.5%, 3.6%, 3.7%, 3.8%, 3.9%, 4% , 4.1%, 4.2%, 4.3%, 4.4%, 4.5%, 4.6%, 4.7%, 4.8%, 4.9%, 5%, 5% , 1%, 5.2%, 5.3%, 5.4%, 5.5%, 5.6%, 5.7%, 5.8%, 5.9%, 6%, 6.1% %, 6.2%, 6.3%, 6.4%, 6.5%, 6.6%, 6.7%, 6.8%, 6.9%, 7%, 7.1%, 7.2%, 7.3%, 7.4%, 7.5%, 7.6%, 7.7%, 7.8%, 7.9% or 8%.
  • Ascorbic acid in the aforementioned proportions, can be added to the other products constituting the composition according to the invention in liquid form or in solid form.
  • the invention relates to the abovementioned composition, in which betaine represents from 13% to 40% by weight relative to the total mass of the composition.
  • the betaine contained in the composition represents, by weight relative to the total weight of the composition 13%, 13.5%, 14%, 14.5%, 15%, 15.5%, 16%, 16.5%, 17%, 17.5%, 18%, 18.5%, 19%, 19.5%, 20%, 20.5%, 21%, 21.5%, 22%, 22%, 5%, 23%, 23.5%, 24%, 24.5%, 25%, 25.5%, 26%, 26.5%, 27%, 27.5%, 28%, 28.5% , 29%, 29.5%, 30%, 30.5%, 31%, 31.5%, 32%, 32.5%, 33%, 33.5%, 34%, 34.5%, 35% %, 35.5%, 36%, 36.5%, 37%, 37.5%, 38%, 38.5%, 39%, 39.5% or 40%.
  • Betaine with a purity greater than or equal to 91% will be preferred.
  • Betaine in the aforementioned proportions, may be added to the other products constituting the composition according to the invention in liquid form or in solid form.
  • the invention relates to the aforementioned composition, wherein said crystalline matrix, consisting of one or more lipids, represents from 25% to 65% by weight relative to the total mass of the composition.
  • the crystalline matrix contained in the composition represents by weight relative to the total mass of the composition 25%, 25.5%, 26%, 26.5%, 27%, 27.5%, 28% , 28.5%, 29%, 29.5%, 30%, 30.5%, 31%, 31.5%, 32%, 32.5%, 33%, 33.5%, 34%, 34% , 5%, 35%, 35.5%, 36%, 36.5%, 37%, 37.5%, 38%, 38.5%, 39%, 39.5%, 40%, 40.5% %, 41%, 41.5%, 42%, 42.5%, 43%, 43.5%, 44%, 44.5%, 45%, 45.5%, 46%, 46.5%, 47%, 47.5%, 48%, 48.5%, 49%, 49.5%, 50%, 50.5%, 51%, 51.5%, 52%, 52.5%, 53% , 53.5%, 54%, 54.5%, 55%, 55.5%, 56%, 56.5%, 57%, 57
  • the invention relates to the composition as defined above, further comprising at least one additional antioxidant agent.
  • composition according to the invention may contain, besides ascorbic acid, one or more antioxidants.
  • Antioxidants are compounds that can attenuate, inhibit or prevent the oxidation of oxidizable materials by preventing the appearance of free radicals and / or by capturing them.
  • Antioxidants are very diverse in terms of nature (enzymatic or not, water-soluble or fat-soluble), origin (endogenous, exogenous, natural, synthetic) or mode of action (preventive, "chain breaking").
  • Said at least one additional antioxidant agent is especially chosen from:
  • antioxidants such as palmityl-6-L-ascorbic acid, tocopherols and alpha-tocopherol, propyl gallate, buthylhydroxyanisol (BHA), butylated hydroxytoluene (BHT) and ethoxyquin,
  • carotenoids and xanthophyls such as beta-carotenes, capsanthin, taurine, lutein, zeaxanthin, citranaxanthin and astaxanthin,
  • polyphenols including flavonoids such as flavone, flavonol, flavonone, dihydroflavonol, isoflavone, isoflavanone, chalone, aurone, anthocyanin, tannins, quercetin, cyanidol, delphinidol and malvidol,
  • vitamins and provitamines such as palmityl-6-L-ascorbic acid, vitamin E, alphatocopheryl acetate and folic acid,
  • trace elements copper, manganese, zinc, selenium (organic form) and iron,
  • antioxidant products natural or synthetic, which can contain several additives or even raw materials, at least one of which has antioxidant activity.
  • Oxidative stress is a break in this balance (lack of antioxidants and / or overproduction of free radicals) and is likely to cause immunodepression in animals.
  • This imbalance can be induced by nutritional failures and / or deficiencies in antioxidants, and in some cases by excessive antioxidants.
  • oxidative stress can appear during certain critical phases and in particular at the time of food imbalances: high food levels, food restriction, consumption of xenobiotics or toxins, micronutrient deficiency, lack of precursor nutrients antioxidants (mainly vitamin E, B-carotene, selenium, copper and zinc), metabolic disorders linked to a significant energy deficit ...; or certain physiological stages: peri-partum period, gestation (mother and fetus), neonatal period.
  • the onset of oxidative stress is also dependent on rearing conditions: climatic variations, emotional stress (confinement, transport, ante-mortem stress); the animal's health status or linked to intense metabolic activity: production of large quantities of milk in dairy cows.
  • Oxidative stress is expressed in animals by stimulation of the enzymes involved in its regulation (glutathione peroxidase, superoxide dismutase, catalase), oxidation of antioxidants in the body (glutathione, thiol proteins, vitamins E, C, A), and the accumulation of oxidation products.
  • the first consequence for the body is the appearance of often irreversible damage to the cell. More broadly, oxidative stress can affect not only product quality but also animal health.
  • the invention relates to the abovementioned composition, wherein said at least one additional antioxidant agent represents, by weight, up to 2% relative to the total mass of the composition.
  • the additional antioxidant agent (s) contained in the composition represent, by weight relative to the total mass of the composition, 0%, 0.1%, 0.2%, 0.3%, 0.4%, 0.5%, 0.6%, 0.7%, 0.8%, 0.9%, 1%, 1.1%, 1.2%, 1.3%, 1.4%, 1, 5%, 1.6%, 1.7%, 1.8%, 1.9% or 2%.
  • the invention relates to the aforementioned composition, further comprising at least one support.
  • Said at least one support is chosen from silica, calcium carbonate, pyrogenic silica, calcium stearate, magnesium stearate and calcium sulphate, calcium formate, bentonite, calcium phosphate, dextrose or a mixture of these.
  • composition according to the invention consists, in mass with respect to the total mass of said composition of:
  • composition according to the invention consists, in mass with respect to the total mass of said composition of:
  • composition according to the invention consists, in mass with respect to the total mass of said composition of:
  • composition of the invention consists, in mass with respect to the total mass of said composition of:
  • folic acid premix 0.5% of a folic acid premix (0.1% of 92% folic acid on a carrier, based on the total mass of the premix)
  • composition of the invention consists, in mass with respect to the total mass of said composition of:
  • composition of the invention consists, in mass with respect to the total mass of said composition of:
  • the invention furthermore relates to a feed intended for the nutrition of farm animals comprising from 0.05% to 0.2% by weight of a composition as defined above with respect to the total mass of the feed.
  • compositions can be added as a supplement or additive to animal feed in proportions ranging from 500g to 2kg per ton of feed. Such proportions represent from 0.05% to 0.2% by weight of composition relative to the total weight of the food. This means that the composition represents, in mass, relative to the total mass of the food, 0.05%, 0.06%, 0.07%, 0.08%, 0.09%, 0.1% , 0.11%, 0.12%, 0.13%, 0.14%, 0.15%, 0.16%, 0.17%, 0.18%, 0.19% or 0.2% .
  • the invention also relates to a method for preparing a composition as defined above, comprising the following steps:
  • composition according to the invention is thus prepared according to a simple process making use of the crystallization properties of lipids and their melting and crystallization temperature.
  • the term "the homogeneous mixture” the action of mixing the various constituents of the composition so that they are distributed in a substantially uniform or uniform manner.
  • said one or more hydrogenated lipids are heated to a temperature that goes beyond the melting point (melting temperature) of the lipid (s) as defined above. Said lipid or lipids are then in liquid form or in pasty form.
  • the active compounds betaine and ascorbic acid
  • the lipid / betaine / ascorbic acid mixture is mixed by any means of mixing or mixing (pestles, spatulas, blades, propellers ).
  • the temperature of the mixture, and in particular the temperature of the lipid or lipids will then gradually decrease until, at first, it falls below the melting temperature of the molten lipids. If the mixture is still stirred (or subjected to mixing), the temperature will decrease below the point of crystallization of said lipid or said inducing a crystallization of this or these.
  • the hydrogenated lipid (s) will gradually crystallize and, because of the agitation, form crystals in the middle of which betaine and ascorbic acid will be finely dispersed, homogeneously or not.
  • composition according to the invention made from refined and hydrogenated rapeseed oil will be obtained according to the following process:
  • the refined hydrogenated rapeseed oil is heated to a temperature above 68 ° C (melting point) to obtain a liquid oil.
  • Betaine and ascorbic acid at room temperature are added to the liquid oil, and the mixture is stirred.
  • crystals of refined and hydrogenated rapeseed oil have formed and betaine and ascorbic acid are found dispersed homogeneously or otherwise between the crystals.
  • the mixing can be carried out by a conventional mixer known to those skilled in the art.
  • composition comprises additional compounds (other than betaine and ascorbic acid), these compounds are added to the molten lipids or in pasty form, together with betaine and ascorbic acid.
  • the invention furthermore relates to a composition
  • a composition comprising ascorbic acid and betaine dispersed in a homogeneous or non-homogeneous manner in a crystalline matrix consisting essentially of one or more hydrogenated lipids that can be obtained, or obtained directly, by the process above.
  • the invention furthermore relates to a composition as defined above, or a food as defined above, for its use for the protection against the effects of heat stress of monogastric animals, especially poultry or farmed pigs. .
  • a monogastric animal corresponds to any animal that does not live in the wild.
  • “Monogastric animals” means monogastric animals raised for the purpose of animal production or conservation, as well as domestic animals.
  • thermoneutrality zone is defined by lower and higher critical ambient temperatures which depend on many criteria: species, physiological stage, sex, level of use for poultry, speed of growth, level of production ... but also environmental factors: relative humidity, habitat, ...
  • thermoneutrality corresponds to a temperature range in which the animal uses little or no of energy to regulate its temperature.
  • thermoneutrality it is observed that the heat loss by radiation and contact becomes limiting in the animal and that the heat loss by evapotranspiration takes on increasing importance.
  • heat loss by evapotranspiration then takes place on the pulmonary mucosal surfaces.
  • Pork adjusts cardiovascular function by increasing blood flow to the subcutaneous and respiratory systems, and by decreasing the flow to highly heat-producing tissues such as the liver, muscles or digestive tract. There is also a change in skin temperature, an improvement in heat loss by radiation and convection related to the increase in vasodilation of subcutaneous arterioles.
  • Heat stress in pigs also significantly affects the feeding behavior of pigs: lower consumption (reduced size of meals coupled with a reduction in the number of meals at certain physiological stages, the only way to maintain homeothermia), transfer of meals to the cooler times of the day.
  • These impacts on feeding behavior have additional effects on the sow: nutritional deficit, mobilization of reserves to maintain piglet growth and milk production.
  • in growing pigs there is a reduction in growth rate, an increase in lean meat in carcasses.
  • the invention furthermore relates to the use of a composition as defined above, for the manufacture of a pharmaceutical or veterinary product, intended for protection against the effects of thermal stress on farmed monogastric animals, especially the poultry or swine.
  • a method for protecting against the effects of thermal stress on monogastric animals comprising the administration to monogastric animals, in particular farmed poultry or pigs, in need, or likely to be in the need, an effective dose of a composition as defined above.
  • FIG. 1 represents histograms showing the activity of the plasma creatine kinase enzyme of 34J chickens, expressed in units / liter, for each of the groups studied: (1): Negative control batch without betaine (gray) dark); (2) Lot with betaine supply of synthetic anhydrous 96% non-vectorized at 500 ppm (gray); (3): batch with betaine anhydrous synthetic 96% vectorized at 500 ppm (light gray).
  • FIG. 2 represents histograms showing the activity of the 34 mg broiler Glutathione Peroxidase (GPx) enzyme, expressed in units / liter, for each of the groups studied: (1): Negative control batch without betaine supply ( dark gray) ; (2) Lot with betaine supply of synthetic anhydrous 96% non-vectorized at 500 ppm (gray); (3): batch with betaine anhydrous synthetic 96% vectorized at 500 ppm (light gray).
  • GPx broiler Glutathione Peroxidase
  • FIG. 3 represents histograms showing the corrected consumption index of the weight of broilers, expressed in g / g, over the period 21-34j for each of the groups studied: (1): Negative control batch without betaine supply ( dark gray) ; (2) Lot with betaine supply of synthetic anhydrous 96% non-vectorized at 500 ppm (gray); (3): batch with betaine anhydrous synthetic 96% vectorized at 500 ppm (light gray).
  • FIG. 4 represents histograms showing the Daily Average Gain (GMQ) of broilers, expressed in g / day, over the period 21-34j, for each of the groups studied: (1): Negative control batch without betaine supply ( dark gray) ; (2) Lot with betaine supply of synthetic anhydrous 96% non-vectorized at 500 ppm (gray); (3): batch with betaine anhydrous synthetic 96% vectorized at 500 ppm (light gray).
  • GMQ Daily Average Gain
  • FIG. 5 shows curves showing the evolution of the average broiler weight, expressed in% of the control group (1), over the period 7-42j for each of the groups studied: (1): Negative control lot (black spots ); (2): Batch with vitamin C and other non-vectorized antioxidants (light gray dots); (3): Lot with contribution of the composition according to the invention (dark gray triangle).
  • FIG. 6 represents a histogram comparing the index of consumption of broilers, expressed in% of the control group (1), over the period 0-45j for each of the groups studied: (1): negative control lot (black); (2): Batch with vitamin C and other non-vectorized antioxidants (dark gray); (3): batch with contribution of the composition according to the invention (light gray).
  • FIG. 7 represents a histogram showing the weight-corrected consumption index (ICC) of broilers at 37j, expressed in g / g, for each of the groups studied: (1): Negative control batch without betaine supplementation or antioxidant (dark gray) ; (2): Lot with betaine HCl synthetic 95% non-vectorized allowing a contribution of 700ppm pure betaine (gray); (3): Batch of betaine HCl synthetic 95% vectorized with hydrogenated palm oil allowing a supply of 350ppm pure betaine (light gray); (4): batch with contribution of the composition according to the invention for a supply of 200 ppm of pure betaine (scratches).
  • ICC weight-corrected consumption index
  • Figure 8 represents a histogram showing the weight of the fillets of broilers, expressed in g, the 0-36j period for each of the groups studied: (1): Lot negative control without supplementation betaine or antioxidant (dark gray); (2): Lot with betaine HCl synthetic 95% non-vectorized allowing a contribution of 700ppm pure betaine (gray); (3): Batch of betaine HCl synthetic 95% vectorized with hydrogenated palm oil allowing a supply of 350ppm pure betaine (light gray); (4): batch with contribution of the composition according to the invention for a supply of 200 ppm of pure betaine (scratches).
  • Example 1 Effects of supplementation betaine and in food antioxidants vectorized on growth performance, oxidative stress and carcass carcass quality maintained at high temperatures
  • the growth performance of broilers and the meat yield are altered by high temperature.
  • Betaine supplementation can reduce these negative effects by virtue of its osmoprotective properties and its role as a methyl donor.
  • vitamin C and other antioxidants can protect against oxidative stress and hemolysis. Since betaine and vitamins are aggressive or sensitive active ingredients, a specific vectorization process with a selected vegetable fat has been applied. The purpose of this study was to evaluate the effect of the composition according to the invention on growth performance, carcass quality and blood hemolysis in broilers reared under hot conditions.
  • a total of 192 male Ross 308 broilers were distributed in a randomized complete block comprising 3 groups: T- (negative control, no composition according to the invention), B1 (T- + 750 g / ton of composition according to the invention). invention) and B2 (T + 1300 g / ton of composition according to the invention), each repeated 16 times with 4 birds per cage. From day 21 to day 35, the temperature was changed daily to simulate high summer temperatures of up to 30 ° C. Growth performance was measured throughout the experiment. At 36 days, the birds were slaughtered. Plasma markers of oxidative stress, as well as blood hemolysis status, were compared between T- and B2. Water loss and yield nets were compared.
  • the data were analyzed using univariate analysis of variance and Tukey's test as a post-hoc test.
  • the composition according to the invention tested in B1 and B2 had a significant effect on body weight gain, consumption and feed efficiency between 0 and 36 days (P ⁇ 0.05).
  • a post hoc analysis revealed that B1 gave the best results for the above parameters (P ⁇ 0.05).
  • the net yield was significantly increased by supplementation via the composition according to the invention, and even more so for B1 (P ⁇ 0.01). Markers of oxidative stress were not significantly affected by dietary intervention.
  • B2 had a hemolysis score lower than that of T- (4.12 g / L vs. 4.44 g / L, p ⁇ 0.05).
  • composition according to the invention means:
  • folic acid premix 0.5% of a folic acid premix (0.1% 92% folic acid on a carrier, based on the total weight of the premix).
  • the objective of this trial was to test a vectorized form of synthetic anhydrous betaine, compared to a non-vectorized form of anhydrous betaine, made in the broiler feed under hot conditions, from 21 to 34 days.
  • the following thermal program was applied from 21 days of age: from 18h to 8h, the chickens are placed at 24 ° C, from 8h to 11h at 28 ° C, from 11h to 15h at 30 ° C and 15h at 18h at 28 ° C.
  • the plasma creatine kinase enzyme is one of the indicators of muscle damage related to a degradation of the function and membrane permeability of muscle cells, which can result in a degradation of meat quality.
  • myopathy related to hyperthermia is characterized in particular by an increase in the plasma activity of this enzyme.
  • the betaine supply (2) and (3) numerically reduced the plasma level of CK compared to the negative control (1) and the betaine vectorized (3) reduced more strongly CK (-20% compared to the control negative) that betain non-vectorized (2) (-9% compared to the negative control).
  • betaine (2) or (3) numerically increases the activity of the GPx enzyme relative to the control group (1), especially for the betaine-vectorized group (3) (+ 12% compared with the negative control ( 1) versus 7% for non-vectorized Betaine (2)).
  • Betaine intake (2) and (3) improved the weight-corrected intake index compared with the control group (1), either via the non-vectorized form (2) (-0.03 points) or the vectorized form (3) (-0.05 points). Same observation for the Daily Mean Gain (GMQ) between 21 and 34 days: + 3.1% and + 3.6% compared to the control group respectively for the free Betaine 500 ppm group (2) and the Betaine vectorized group 500 ppm (3).
  • GMQ Daily Mean Gain
  • the objective of this test is to compare the effects of the composition according to the invention (3) with a contribution of non-vectorized antioxidants (2) on the growth performance of meat fowl raised under tropical temperatures.
  • test was carried out at an experimental station in Dakar, Senegal, in hot conditions (maximum temperature of 30 ° C). 810 Cobb500 chickens were allotted to 0 days at the rate of 54 chickens per floor, and 5 floors per group.
  • non-vectorized antioxidants (2) and of the composition according to the invention (3) in the broiler chickens reared under the conditions of rearing of the tropical zones makes it possible to significantly improve the weights of the chickens compared with the control. negative (1), respectively by 5% and 7% at 42 days.
  • the viability of the animals is improved with the addition of non-vectorized antioxidants (2) and the composition according to the invention (3), since the mortality decreases by 47% and 52% respectively relative to the negative control (1). .
  • composition according to the invention (3) in which the antioxidants are vectorized and combined with betaine, although the antioxidants are provided in a smaller quantity (up to three times less) than batch (2) not containing betaine,
  • the objective of the test is to compare the effects of the composition according to the invention (4) in comparison with a supply of free betaine (2) and betaine vectorized (3) on growth performance, stress markers. oxidation and the quality of broiler carcasses subjected to high ambient temperatures compared to the seasonal norm.
  • the test was carried out in experimental station.
  • the 256 chickens were allotted at 0 days at the rate of 4 Ross 308 male chickens per module, divided into 4 groups of 16 modules, ie 64 chickens per group.
  • the chickens were subjected to the following thermal program: 28 ° C from 8h to 11h, 30 ° C from 11h to 15h, 28 ° C from 15h to 18h, 24 ° C from 18h to 8h.
  • the animals were slaughtered at 37 days of age, and the net quality was raised.
  • Zootechnical performance was measured throughout the trial period: animal weight, feed consumption, water consumption, scoring and dry matter of droppings, mortality (number, cause).
  • the weight-adjusted consumption index (ICC) 0-36j is improved numerically by the addition of the 3 solutions (1), (2) and (3) compared to the negative control (1).
  • the ICC is significantly improved by -0.06 points with respect to the negative control (1) for the group with the composition according to the invention (4).
  • variable net weight (g) at 37j There is also a significant group effect on the variable net weight (g) at 37j.
  • the group Composition according to the invention (4) improves the weight of nets of + 46.8g compared to the negative control (1).
  • betaine makes it possible to obtain results comparable to a betaine free double-dose (3) dose: 350 ppm vs (2): 700 ppm.
  • composition according to the invention (4), for a lesser betaine equivalent dose (200 ppm), makes it possible to further improve performance with respect to a simple provision of betaine, vectorized (3) or not (2).
  • composition according to the invention is the product which shows the best zootechnical performance and the best slaughtering performance with a significant net weight gain.
  • the objective of this test was to test the effectiveness of the composition according to the invention, under summer conditions, on broilers between 29 and 33 days of age.
  • composition according to the invention was incorporated into the last food at 1 kg / T and distributed to 47 000 broilers distributed in 1 control building (20 000 chickens) and 1 test building (27 000 chickens) in the same farm, located in the northwestern France, end of August.
  • composition according to the invention consisted of:
  • the animals in the control group did not receive any supplement to the feed usually used by the farmer.
  • the animals of the test group received, in addition to the food, the composition according to the invention at 1 kg / ton of food of 29 to 33 days of age.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biotechnology (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

The invention relates to a composition comprising an active substance dispersed in a matrix, said active substance comprising or consisting substantially of a mixture of betaine and ascorbic acid, said matrix being a crystalline matrix consisting substantially of hydrogenated lipids.

Description

Composition contre les stressComposition against stress

L’invention concerne une composition contribuant à la réduction des effets de conditions non optimales, notamment contre les effets des stress chez les animaux.The invention relates to a composition that contributes to reducing the effects of non-optimal conditions, particularly against the effects of stress in animals.

Lorsque les températures augmentent et atteignent des seuils élevés, les animaux peuvent être confrontés au phénomène de stress thermique et n'arrivent plus à réguler leur propre température corporelle. Cela entraîne des effets néfastes pour leur santé, tels qu'un affaiblissement de leur résistance aux maladies et une diminution de leur croissance. C'est pourquoi il est primordial de prendre à temps les mesures qui s'imposent en vue d'éviter le stress thermique chez les animaux, notamment les animaux d’élevage, particulièrement chez les porcs, les bovins, les volailles ou encore les caprins.When temperatures rise and reach high thresholds, animals may be confronted with the phenomenon of heat stress and can no longer regulate their own body temperature. This results in adverse health effects, such as reduced disease resistance and decreased growth. That is why it is essential to take the necessary measures in time to avoid heat stress in animals, especially farm animals, particularly in pigs, cattle, poultry and goats. .

Afin d’améliorer et de développer la productivité en zone tropicale, d’anticiper les changements climatiques qui affectent ou affecteront de plus en plus les zones d’élevage tempérées, il est nécessaire de prendre en considération les effets du stress thermique afin d’adapter des systèmes d’élevage à un environnement climatique changeant, quelle que soit la zone climatique.In order to improve and develop productivity in the tropics, to anticipate climate changes that affect or will affect more and more temperate farming areas, it is necessary to take into account the effects of heat stress in order to adapt from farming systems to a changing climate environment, regardless of the climate zone.

L’adaptation en élevage décrit la faculté d’un animal à faire face aux contraintes de l’environnement, en mobilisant ses principales fonctions physiologiques. L’objectif du processus adaptatif pour l’animal est de maintenir son bien-être et de garantir sa survie (homéostase) et celle de sa descendance (homéorhèse).Adaptation in breeding describes the ability of an animal to cope with the constraints of the environment, by mobilizing its main physiological functions. The objective of the adaptive process for the animal is to maintain its well-being and to guarantee its survival (homeostasis) and that of its offspring (homeorhesis).

Le stress thermique apparaît à partir du moment où la température ambiante excède la zone de moindre effort de thermorégulation ou zone de thermoneutralité.The thermal stress appears from the moment when the ambient temperature exceeds the zone of least effort of thermoregulation or zone of thermoneutrality.

Lorsque la température ambiante augmente au-delà de cette zone de thermoneutralité, les mécanismes de régulation (réduction de la thermogenèse/augmentation de la thermolyse) sont saturés et l’animal ne parvient plus à maintenir sa température interne constante.When the ambient temperature rises beyond this zone of thermoneutrality, the mechanisms of regulation (reduction of the thermogenesis / increase of the thermolysis) are saturated and the animal is no longer able to maintain its internal temperature constant.

Le stress thermique est un problème survenant à la suite soit d’une hausse brusque et ponctuelle des températures (coup de chaleur, canicule), soit d’une hausse prolongée des températures sur une période plus longue (été, climat tropical). Thermal stress is a problem that occurs as a result of a sudden and occasional rise in temperature (heat stroke, heat wave), or a prolonged rise in temperatures over a longer period (summer, tropical climate).

L’animal n’est plus en mesure de réguler sa température corporelle, ce qui entraîne des baisses de performance importantes en élevage et donc des pertes économiques. Les équipements des bâtiments d’élevage ne suffisent pas toujours à éviter cette situation. The animal is no longer able to regulate its body temperature, which leads to significant performance losses in breeding and therefore economic losses. The equipment of livestock buildings is not always enough to avoid this situation.

Le stress thermique peut être défini comme étant la somme des forces extérieures à un animal homéotherme (c’est-à-dire un animal qui conserve une température corporelle constante indépendamment du milieu extérieur), qui agissent pour modifier sa température corporelle par rapport à l’état normal. Heat stress can be defined as the sum of forces external to a warm-blooded animal (that is, an animal that maintains a constant body temperature independently of the external environment), which act to alter its body temperature relative to the temperature of the body. normal state.

En raison de leur mode d’élevage, et de leur faible aptitude à perdre de la chaleur par évaporation (absence de glandes sudoripares efficientes), les animaux monogastriques d’élevage sont particulièrement sensibles à la chaleur, et donc au stress thermique. Notamment, la convection et la radiation jouent un faible rôle dans la dissipation de la chaleur chez les volailles du fait de l’isolation efficace de la surface du corps assurée par les plumes. L’absence de glandes sudoripares fonctionnelles et la faible perspiration limitent la capacité des volailles à maintenir une température lors d’un épisode de chaleur. Because of their breeding mode, and their low ability to lose heat by evaporation (absence of efficient sweat glands), farmed monogastric animals are particularly sensitive to heat, and therefore to heat stress. In particular, convection and radiation play a small role in the heat dissipation in poultry because of the effective insulation of the body surface provided by the feathers. The absence of functional sweat glands and low perspiration limit the ability of poultry to maintain a temperature during a heat episode.

Les effets induits par les mécanismes de lutte contre le stress thermiques sont : The effects induced by the heat stress mechanisms are:

Troubles du comportement (picage, agressivité),Behavioral disorders (pecking, aggression),

Baisse des ingérés (en quantité et/ou en fréquence de repas) et donc baisse des croissances,Lower ingested (in quantity and / or frequency of meals) and therefore lower growth,

Hyperventilation (becs ouverts, alcalose, déséquilibre ionique…)Hyperventilation (open beaks, alkalosis, ionic imbalance ...)

Dégradation de la qualité des carcasses (chez les volailles : viandes PSE « Pale, Soft, Exsudative » ou viandes pâles, molles et exsudatives en français, en lien avec une chute rapide du pH post mortem), viandes plus grasses, défaut de pigmentation ; chez les porcs : augmentation du taux de viande maigre)Degradation of carcass quality (in poultry: "Pale, Soft, Exudative" PSE meat or pale, soft and exudative meat in French, linked to a rapid drop in post-mortem pH), fatter meats, lack of pigmentation; in pigs: increase in lean meat rate)

Depuis quelques années, se mettent en place différentes solutions techniques, génétiques ou nutritionnelles, pour limiter la mortalité et favoriser la croissance des animaux monogastriques d’élevage, et notamment des poulets élevés en ambiance chaude.In recent years, various technical, genetic or nutritional solutions have been put in place to limit mortality and promote the growth of farmed monogastric animals, particularly chickens raised in a hot environment.

Les stratégies mises en place pour réduire les effets négatifs de la chaleur vont dépendre du type de stress thermique auquel les animaux sont exposés. Lors d’une exposition ponctuelle (coup de chaleur), les solutions sont essentiellement techniques (amélioration des bâtiments et adaptation des techniques d’élevage). Dans le cas d’une exposition prolongée ou chronique, des solutions nutritionnelles ou génétiques peuvent être envisagées pour améliorer la croissance des animaux.Strategies put in place to reduce the negative effects of heat will depend on the type of heat stress to which the animals are exposed. During a punctual exhibition (heat stroke), the solutions are essentially technical (improvement of buildings and adaptation of breeding techniques). In the case of prolonged or chronic exposure, nutritional or genetic solutions may be considered to improve the growth of animals.

On connaît notamment une composition décrite dans le brevet FR3017778 B1 consistant en un extrait de Scutellaria Baicalensis. Cette composition est élaborée à partir d’un complexe d’ingrédients actifs naturels, sélectionnés pour leur effet synergique, et en particulier de la Baïcaline.A composition described in patent FR3017778 B1 consisting of an extract of Scutellaria is known in particular. Baicalensis . This composition is prepared from a complex of natural active ingredients, selected for their synergistic effect, and in particular Baalkaline.

Toutefois, des compositions visant à limiter ou à lutter contre les effets du stress thermique sont toujours à l’étude.However, compositions aimed at limiting or combating the effects of heat stress are still under study.

L’invention vise donc à pallier ces manques de l’art antérieur.The invention therefore aims to overcome these shortcomings of the prior art.

Un des objectifs de l’invention est de proposer une composition simple d’utilisation, facile à produire, et comprenant des composés naturels efficaces le stress thermique et ses effets physiologiques.One of the objectives of the invention is to provide a composition easy to use, easy to produce, and comprising natural compounds effective thermal stress and its physiological effects.

Un autre but de l’invention est de proposer un procédé de fabrication d’une telle composition.Another object of the invention is to provide a method of manufacturing such a composition.

L’invention concerne une composition comprenant une substance active dispersée dans une matrice, ladite substance active comprenant ou étant essentiellement constituée d’un mélange de bétaïne et d’un agent antioxydant, ledit agent antioxydant étant l’acide ascorbique, ladite matrice étant une matrice cristalline essentiellement constituée d’un ou plusieurs lipides hydrogénés, notamment de l’huile hydrogénée. The invention relates to a composition comprising an active substance dispersed in a matrix, said active substance comprising or consisting essentially of a mixture of betaine and an antioxidant agent, said antioxidant agent being ascorbic acid, said matrix being a matrix crystalline essentially consisting of one or more hydrogenated lipids, especially hydrogenated oil.

L’invention repose sur la constatation inattendue faite par les inventeurs qu’une composition comprenant de la bétaïne et un antioxydant tel que la vitamine C (acide ascorbique), sous forme vectorisée dans une matrice cristalline présente de très bons effets sur le stress thermique et ses conséquences.The invention is based on the unexpected finding made by the inventors that a composition comprising betaine and an antioxidant such as vitamin C (ascorbic acid), in vectorized form in a crystalline matrix has very good effects on heat stress and its consequences.

Les inventeurs ont en effet observé que la composition selon l’invention agit par synergies des composés actifs (bétaïne et antioxydant, notamment l’acide ascorbique ou vitamine C), et favorise la résistance des animaux monogastriques d’élevage au stress thermique, soutient les défenses naturelles desdits animaux et permet d’améliorer les performances zootechniques.The inventors have indeed observed that the composition according to the invention acts by synergy of the active compounds (betaine and antioxidant, in particular ascorbic acid or vitamin C), and promotes the resistance of monogastric animals raised to heat stress, supports the natural defenses of said animals and improves zootechnical performance.

La composition de l’invention comprend de la bétaïne qui est une substance de formule (CH3)3N+CCOO-, disponible sous forme liquide ou cristalline. The composition of the invention comprises betaine which is a substance of formula (CH 3 ) 3 N + CCOO - , available in liquid or crystalline form.

La bétaïne anhydre d’origine naturelle, est extraite de la molasse ou la vinasse de plantes et des racines de celles-ci, principalement de betterave (Beta vulgaris), en particulier dérivés de la fabrication de sucre ou de bioéthanol. La bétaïne est séparée et purifiée par chromatographie, avec ou sans solvant organique (de type méthanol, dichlorométhane, ou chloroforme), en phase liquide ou phase solide. Les bétaïnes anhydres se présentent sous une forme solide ou liquide. Les bétaïnes anhydres solides ont un taux de pureté variant de 91 à 97%.Anhydrous betaine of natural origin, is extracted from the molasse or vinasse plants and roots thereof, mainly beet ( Beta vulgaris ), especially derived from the manufacture of sugar or bioethanol. Betaine is separated and purified by chromatography, with or without an organic solvent (of the methanol, dichloromethane or chloroform type), in the liquid phase or in the solid phase. The anhydrous betaines are in solid or liquid form. Solid anhydrous betaines have a purity level ranging from 91 to 97%.

La bétaïne de synthèse est obtenue à partir d’acide chloroacétique et de carbonate de sodium, auxquels on ajoute de la triméthylamine. Les bétaïnes de synthèse se présentent sous une forme solide ou liquide. On distingue la bétaïne HCl ou hydrochloride (ajout d’acide hydrochloride après une étape de concentration du mélange d’acide chloroacétique et de carbonate de sodium) de la bétaïne monohydrate ou anhydrate. Les bétaïnes de synthèse HCl solides ont de manière générale un taux de pureté compris entre 93 et 98%, les monohydrates solides ont une pureté aux alentours de 91% et les anhydrates solides une pureté aux alentours de 96%.Synthetic betaine is obtained from chloroacetic acid and sodium carbonate, to which trimethylamine is added. The synthetic betaines are in solid or liquid form. Betaine HCl or hydrochloride (addition of hydrochloride acid after a concentration step of the mixture of chloroacetic acid and sodium carbonate) of betaine monohydrate or anhydrate. The solid HCl synthetic betaines generally have a degree of purity of between 93 and 98%, the solid monohydrates have a purity of around 91% and solid anhydrates a purity of around 96%.

Les bétaïnes liquides ont quant à elles un taux de pureté plus bas, compris entre 38 et 47%.Liquid betaines have a lower purity level of between 38 and 47%.

La bétaïne joue un rôle osmorégulateur. D’une part, la protection de l’épithélium intestinal contre les modifications osmotiques favorise l’absorption des nutriments et améliore ainsi les performances zootechniques. D’autre part, le maintien de la pression osmotique protège les cellules de la déshydratation, ce qui est favorable à leur fonctionnement métabolique normal. Une amélioration des rendements avec l’apport de bétaïne est régulièrement observée dans la littérature, et pourrait être mise en relation avec une meilleure rétention en eau des cellules. Betaine plays an osmoregulatory role. On the one hand, the protection of the intestinal epithelium against osmotic changes promotes the absorption of nutrients and thus improves zootechnical performance. On the other hand, the maintenance of osmotic pressure protects the cells from dehydration, which is favorable to their normal metabolic functioning. An improvement in yields with betaine intake is regularly observed in the literature, and could be related to better water retention of the cells.

La composition selon l’invention contient également au moins un antioxydant qui est de l’acide ascorbique (acide oxo-3-gulofuranolactone ou vitamine C), bien connu de l’homme du métier.The composition according to the invention also contains at least one antioxidant which is ascorbic acid (oxo-3-gulofuranolactone acid or vitamin C), which is well known to those skilled in the art.

La composition selon l’invention est caractérisée en ce que la bétaïne et l’antioxydant sont dispersés de manière homogène dans une matrice cristalline essentiellement constituée d’un ou plusieurs lipides hydrogénés.The composition according to the invention is characterized in that the betaine and the antioxidant are dispersed homogeneously in a crystalline matrix consisting essentially of one or more hydrogenated lipids.

Dans l’invention, on entend par « un ou plusieurs lipides » un mélange de lipides comprenant un seul type de lipide ou un mélange de plusieurs types de lipides de natures différentes (et donc de structures chimiques différentes). Par conséquent, dans toute la description qui précède et qui suit, les termes « un ou plusieurs lipides » peuvent être uniformément remplacés par les termes « un mélange d’un type ou un mélange de plusieurs types différents de lipides ».In the invention, the term "one or more lipids" is understood to mean a lipid mixture comprising a single type of lipid or a mixture of several types of lipids of different natures (and therefore of different chemical structures). Therefore, throughout the foregoing and following description, the terms "one or more lipids" may be uniformly replaced by the terms "a mixture of one type or a mixture of several different types of lipids".

Dans l’invention, les lipides sont avantageusement un ou plusieurs lipides hydrogénés, notamment de l’huile hydrogénée, ou des dérivés d'huile hydogénée, tels que des acides gras hydrogénés ou alcools gras hydrogénés ces derniers pouvant être sous forme libre ou sous forme d'esters d'acide gras monoglycérol, di ou polyglycérol. Aussi, dans le cadre d’une matrice cristalline de l’invention composée de lipides cette matrice est donc essentiellement constituée d’un ou plusieurs lipides hydrogénés, notamment de l’huile hydrogénée, ou des dérivés d'huile hydogénée, tels que des acides gras hydrogénés ou alcools gras hydrogénés ces derniers pouvant être sous forme libre ou sous forme d'esters d'acide gras monoglycérol, di ou polyglycérolIn the invention, the lipids are advantageously one or more hydrogenated lipids, in particular hydrogenated oil, or hydogenated oil derivatives, such as hydrogenated fatty acids or hydrogenated fatty alcohols, the latter being able to be in free form or in the form of hydrogenated of monoglycerol, di or polyglycerol fatty acid esters. Also, in the context of a crystalline matrix of the invention composed of lipids, this matrix is essentially composed of one or more hydrogenated lipids, in particular hydrogenated oil, or derivatives of hydogenated oil, such as acids. hydrogenated fats or hydrogenated fatty alcohols, the latter being in free form or in the form of monoglycerol, di or polyglycerol fatty acid esters

Dans un autre aspect avantageux, les lipides constituants ladite matrice cristalline sont les lipides d’une huile, notamment une huile végétale ou animale. A titre d’exemple et sans pour autant limiter la portée de l’invention, les huiles envisagées sont en particulier les suivantes :In another advantageous aspect, the lipids constituting said crystalline matrix are the lipids of an oil, especially a vegetable or animal oil. By way of example and without limiting the scope of the invention, the oils envisaged are in particular the following:

les huiles végétales telles que l’huile de colza, l’huile de colza oléique, l’huile de tournesol, l’huile de tournesol oléique, l’huile de coco, l’huile de palme, l’huile palmiste, l’huile d’olive, l’huile d’arachide, l’huile de soja, l’huile de maïs, l’huile de moutarde, l’huile de ricin, l’oléine de palme, la stéarine de palme, l’huile de carthame, l’huile de sésame, l’huile de lin, l’huile de noix, l’huile de pépins de raisin, l’huile de chanvre,vegetable oils such as rapeseed oil, oleic rapeseed oil, sunflower oil, oleic sunflower oil, coconut oil, palm oil, palm kernel oil, olive oil, peanut oil, soybean oil, corn oil, mustard oil, castor oil, palm olein, palm stearin, oil Safflower, sesame oil, linseed oil, walnut oil, grape seed oil, hemp oil,

les huiles et graisses animales telles que les huiles de poissons, notamment de poissons gras,animal oils and fats such as fish oils, especially fatty fish,

les huiles microbiennes issues de microorganismes dits oléagineux, c’est-à-dire capables de stocker des acides gras à plus de 20% de leur poids sec, issus de levures, de bactéries, notamment du genre Streptomycès, ou de micro-algues,microbial oils derived from so-called oleaginous microorganisms, that is to say capable of storing fatty acids containing more than 20% of their dry weight, originating from yeasts, bacteria, in particular the genus Streptomycès , or micro-algae,

ou un sous-produit issu de l’extraction des huiles susmentionnées comprenant un mélange d’acides gras, comme les eaux d’estérifications, les fonds de bacs, les condensats de désodorisation, les eaux de lavages ou les pâtes de neutralisation.or a by-product derived from the extraction of the above-mentioned oils comprising a mixture of fatty acids, such as esterification waters, bottoms, deodorizing condensates, washings or neutralization pastes.

Les lipides dans l’invention sont choisis afin que les compositions qui les comprennent soient solides, semi-solides ou plastiques à une température ambiante, c’est-à-dire à une température comprise entre 15°C et 40°C, notamment de 17°C à 30°C. Ces lipides sont notamment des lipides hydogénés par hydrogénation, notamment catalytique. The lipids in the invention are chosen so that the compositions which comprise them are solid, semi-solid or plastics at an ambient temperature, that is to say at a temperature of between 15 ° C. and 40 ° C., especially of 17 ° C to 30 ° C. These lipids are in particular hydrogenated lipids by hydrogenation, in particular catalytic.

Dans le cadre de l’hydrogénation, les triglycérides sont traités par exemple en présence d'hydrogène moléculaire et d'un catalyseur (notamment du cuivre ou du nickel ou palladium) à une température de 140°C à 250°C. Ce type de réaction est hétérogène car il y a trois phases en présence : une phase gazeuse avec l'hydrogène, une phase liquide avec les triglycérides à hydrogéner et une phase solide avec le catalyseur finement divisé. La réaction est exothermique et dégage de l'ordre de 100 à 150 kJ par mole de double liaison. L'hydrogénation peut être sélective, il s'agira par exemple de diminuer spécifiquement le taux d'acide linolénique (C18:3) d’une huile pour obtenir de l’acide linoléique (C18:2). Ce type d'hydrogénation vise à saturer dans une forte proportion, voire parfois totalement, les doubles liaisons des acides gras insaturés contenus dans les triglycérides d’une huile. In the context of hydrogenation, the triglycerides are treated for example in the presence of molecular hydrogen and a catalyst (in particular copper or nickel or palladium) at a temperature of 140 ° C to 250 ° C. This type of reaction is heterogeneous because there are three phases present: a gaseous phase with hydrogen, a liquid phase with the triglycerides to be hydrogenated and a solid phase with the finely divided catalyst. The reaction is exothermic and evolves on the order of 100 to 150 kJ per mole of double bond. The hydrogenation can be selective, it will be for example to specifically reduce the linolenic acid (C18: 3) of an oil to obtain linoleic acid (C18: 2). This type of hydrogenation aims to saturate in a large proportion, or sometimes totally, the double bonds of the unsaturated fatty acids contained in the triglycerides of an oil.

Les huiles hydrogénées selon l’invention sont les suivantes : l’huile de palme raffinée et hydrogénée dont le point de fusion varie de 60 à 63°C, l’huile de tournesol hydrogénée dont le point de fusion varie de 69 à 73°C, l’huile de colza raffinée et hydrogénée dont le point de fusion varie de 68 à 74°C et la stéarine de palme (comprenant des acides gras en C16-C18) dont le point de fusion varie de 56 à 62 °C. The hydrogenated oils according to the invention are the following: refined and hydrogenated palm oil whose melting point varies from 60 to 63 ° C., hydrogenated sunflower oil whose melting point varies from 69 to 73 ° C. , refined and hydrogenated rapeseed oil having a melting point of 68 to 74 ° C and palm stearin (comprising C16-C18 fatty acids) having a melting point of 56 to 62 ° C.

D’autres huiles intéressantes dans le cadre de l’invention peuvent être utilisées : l’huile de soja (non OGM) dont le point de fusion varie de 68 à 71°C ou encore l’huile de colza (haut érucique), contant des acides gras saturés à partir de C12 ou C14, et dont le point de fusion varie de 61 à 66°C.Other oils of interest in the context of the invention can be used: soybean oil (non-GMO) whose melting point varies from 68 to 71 ° C or rapeseed oil (erucic high), saturated fatty acids from C12 or C14, and whose melting point ranges from 61 to 66 ° C.

Dans certains aspects de la composition selon l’invention il est également possible de mélanger des lipides selon l’invention présentant un point de fusion élevé, au au-delà de 55°C, avec des lipides selon l’invention dont le point de fusion est en deçà de 55°C. Dans ce cas, il convient de s’assurer que le point de fusion du mélange sera au-dessus de 55°C.In certain aspects of the composition according to the invention it is also possible to mix lipids according to the invention having a high melting point, at above 55 ° C., with lipids according to the invention whose melting point is below 55 ° C. In this case, it must be ensured that the melting point of the mixture will be above 55 ° C.

Par exemple, il sera possible de réaliser un mélange d’huiles de palmiste hydrogénées, dont le point de fusion est de 39°C avec une ou plusieurs huiles hydrogénées ayant un point de fusion supérieur à 65°C, de sorte que le point de fusion global du mélange huile de palmite et autres huiles soit supérieur à 55°C. Il en va de même pour des huiles de coprah hydrogénées ayant un point de fusion de 30 à 32 °C.For example, it will be possible to make a mixture of hydrogenated palm kernel oils having a melting point of 39 ° C with one or more hydrogenated oils having a melting point above 65 ° C, so that the overall melting of the palmite oil and other oils mixture is greater than 55 ° C. The same is true for hydrogenated coconut oils having a melting point of 30 to 32 ° C.

Les températures de cristallisation de ces mêmes huiles hydrogénées sont les suivantes :The crystallization temperatures of these same hydrogenated oils are as follows:

environ 47°C pour l’huile de palme raffinée et hydrogénée,about 47 ° C for refined and hydrogenated palm oil,

environ 49°C pour l’huile de tournesol hydrogénée,about 49 ° C for hydrogenated sunflower oil,

environ 49° pour l’huile de colza raffinée et hydrogénée,about 49 ° for refined and hydrogenated rapeseed oil,

environ 37°C pour la stéarine de palme,about 37 ° C for palm stearin,

environ 48°C pour l’huile de soja (non OGM), etabout 48 ° C for soybean oil (non-GMO), and

environ 55°C pour l’huile de colza (haut érucique).about 55 ° C for rapeseed oil (erucic high).

Avantageusement, l’invention concerne la composition susmentionnée, dans laquelle l’acide ascorbique représente de 2,5% à 8% en masse par rapport à la masse totale de la composition.Advantageously, the invention relates to the abovementioned composition, in which the ascorbic acid represents from 2.5% to 8% by weight relative to the total mass of the composition.

Dans l’invention, l’acide ascorbique contenu dans la composition représente en masse par rapport à la masse totale de la composition 2,5%, 2,6%, 2,7%, 2,8%, 2,9%, 3%, 3,1%, 3,2%, 3,3%, 3,4%, 3,5%, 3,6%, 3,7%, 3,8%, 3,9%, 4%, 4,1%, 4,2%, 4,3%, 4,4%, 4,5%, 4,6%, 4,7%, 4,8%, 4,9%, 5%, 5,1%, 5,2%, 5,3%, 5,4%, 5,5%, 5,6%, 5,7%, 5,8%, 5,9%, 6%, 6,1%, 6,2%, 6,3%, 6,4%, 6,5%, 6,6%, 6,7%, 6,8%, 6,9%, 7%, 7,1%, 7,2%, 7,3%, 7,4%, 7,5%, 7,6%, 7,7%, 7,8%, 7,9% ou 8%.In the invention, the ascorbic acid contained in the composition represents, by weight relative to the total mass of the composition, 2.5%, 2.6%, 2.7%, 2.8%, 2.9%, 3%, 3.1%, 3.2%, 3.3%, 3.4%, 3.5%, 3.6%, 3.7%, 3.8%, 3.9%, 4% , 4.1%, 4.2%, 4.3%, 4.4%, 4.5%, 4.6%, 4.7%, 4.8%, 4.9%, 5%, 5% , 1%, 5.2%, 5.3%, 5.4%, 5.5%, 5.6%, 5.7%, 5.8%, 5.9%, 6%, 6.1% %, 6.2%, 6.3%, 6.4%, 6.5%, 6.6%, 6.7%, 6.8%, 6.9%, 7%, 7.1%, 7.2%, 7.3%, 7.4%, 7.5%, 7.6%, 7.7%, 7.8%, 7.9% or 8%.

L’acide ascorbique, dans les proportions susmentionnées, peut être ajouté aux autres produits constituant la composition selon l’invention sous forme liquide ou sous forme solide.Ascorbic acid, in the aforementioned proportions, can be added to the other products constituting the composition according to the invention in liquid form or in solid form.

Avantageusement, l’invention concerne la composition susmentionnée, dans laquelle la bétaïne représente de 13% à 40% en masse par rapport à la masse totale de la composition.Advantageously, the invention relates to the abovementioned composition, in which betaine represents from 13% to 40% by weight relative to the total mass of the composition.

Dans l’invention, la bétaïne contenue dans la composition représente en masse par rapport à la masse totale de la composition 13%, 13,5%, 14%, 14,5%, 15%, 15,5%, 16%, 16,5%, 17%, 17,5%, 18%, 18,5%, 19%, 19,5%, 20%, 20,5%, 21%, 21,5%, 22%, 22,5%, 23%, 23,5%, 24%, 24,5%, 25%, 25,5%, 26%, 26,5%, 27%, 27,5%, 28%, 28,5%, 29%, 29,5%, 30%, 30,5%, 31%, 31,5%, 32%, 32,5%, 33%, 33,5%, 34%, 34,5%, 35%, 35,5%, 36%, 36,5%, 37%, 37,5%, 38%, 38,5%, 39%, 39,5% ou 40%.In the invention, the betaine contained in the composition represents, by weight relative to the total weight of the composition 13%, 13.5%, 14%, 14.5%, 15%, 15.5%, 16%, 16.5%, 17%, 17.5%, 18%, 18.5%, 19%, 19.5%, 20%, 20.5%, 21%, 21.5%, 22%, 22%, 5%, 23%, 23.5%, 24%, 24.5%, 25%, 25.5%, 26%, 26.5%, 27%, 27.5%, 28%, 28.5% , 29%, 29.5%, 30%, 30.5%, 31%, 31.5%, 32%, 32.5%, 33%, 33.5%, 34%, 34.5%, 35% %, 35.5%, 36%, 36.5%, 37%, 37.5%, 38%, 38.5%, 39%, 39.5% or 40%.

On privilégiera une bétaïne de pureté supérieure ou égale à 91%.Betaine with a purity greater than or equal to 91% will be preferred.

La bétaïne, dans les proportions susmentionnées, peut être ajouté aux autres produits constituant la composition selon l’invention sous forme liquide ou sous forme solide.Betaine, in the aforementioned proportions, may be added to the other products constituting the composition according to the invention in liquid form or in solid form.

Avantageusement, l’invention concerne la composition susmentionnée, dans laquelle ladite matrice cristalline, constituée d’un ou plusieurs lipides, représente de 25% à 65% en masse par rapport à la masse totale de la composition.Advantageously, the invention relates to the aforementioned composition, wherein said crystalline matrix, consisting of one or more lipids, represents from 25% to 65% by weight relative to the total mass of the composition.

Dans l’invention, la matrice cristalline contenue dans la composition représente en masse par rapport à la masse totale de la composition 25%, 25,5%, 26%, 26,5%, 27%, 27,5%, 28%, 28,5%, 29%, 29,5%, 30%, 30,5%, 31%, 31,5%, 32%, 32,5%, 33%, 33,5%, 34%, 34,5%, 35%, 35,5%, 36%, 36,5%, 37%, 37,5%, 38%, 38,5%, 39%, 39,5%, 40%, 40,5%, 41%, 41,5%, 42%, 42,5%, 43%, 43,5%, 44%, 44,5%, 45%, 45,5%, 46%, 46,5%, 47%, 47,5%, 48%, 48,5%, 49%, 49,5%, 50%, 50,5%, 51%, 51,5%, 52%, 52,5%, 53%, 53,5%, 54%, 54,5%, 55%, 55,5%, 56%, 56,5%, 57%, 57,5%, 58%, 58,5%, 59%, 59,5%, 60%, 60,5%, 61%, 61,5%, 62%, 62,5%, 63%, 63,5%, 64%, 64,5% ou 65%.In the invention, the crystalline matrix contained in the composition represents by weight relative to the total mass of the composition 25%, 25.5%, 26%, 26.5%, 27%, 27.5%, 28% , 28.5%, 29%, 29.5%, 30%, 30.5%, 31%, 31.5%, 32%, 32.5%, 33%, 33.5%, 34%, 34% , 5%, 35%, 35.5%, 36%, 36.5%, 37%, 37.5%, 38%, 38.5%, 39%, 39.5%, 40%, 40.5% %, 41%, 41.5%, 42%, 42.5%, 43%, 43.5%, 44%, 44.5%, 45%, 45.5%, 46%, 46.5%, 47%, 47.5%, 48%, 48.5%, 49%, 49.5%, 50%, 50.5%, 51%, 51.5%, 52%, 52.5%, 53% , 53.5%, 54%, 54.5%, 55%, 55.5%, 56%, 56.5%, 57%, 57.5%, 58%, 58.5%, 59%, 59% , 5%, 60%, 60.5%, 61%, 61.5%, 62%, 62.5%, 63%, 63.5%, 64%, 64.5% or 65%.

Dans un autre aspect avantageux, l’invention concerne la composition telle que définie précédemment, comprenant en outre au moins un agent antioxydant additionnel.In another advantageous aspect, the invention relates to the composition as defined above, further comprising at least one additional antioxidant agent.

La composition selon l’invention peut contenir, outre l’acide ascorbique, un ou plusieurs antioxydants. Les antioxydants sont des composés qui peuvent atténuer, inhiber ou prévenir l’oxydation des matières oxydables en prévenant l’apparition de radicaux libres et/ou en les captant. The composition according to the invention may contain, besides ascorbic acid, one or more antioxidants. Antioxidants are compounds that can attenuate, inhibit or prevent the oxidation of oxidizable materials by preventing the appearance of free radicals and / or by capturing them.

Les antioxydants sont très diversifiés en termes de nature (enzymatique ou non, hydrosoluble ou liposoluble), d’origine (endogène, exogène, naturelle, synthétique) ou de mode d’action (préventif, « chain breaking »). Antioxidants are very diverse in terms of nature (enzymatic or not, water-soluble or fat-soluble), origin (endogenous, exogenous, natural, synthetic) or mode of action (preventive, "chain breaking").

Ledit au moins un agent antioxydant additionnel est notamment choisi parmi : Said at least one additional antioxidant agent is especially chosen from:

- les antioxygènes tels que l’acide palmityl-6-L-ascorbique, les tocophénols et alpha-tocophérol, le gallate de propyle, le buthylhydroxyanisol (BHA), le buthylhydroxytoluène (BHT) et l’éthoxyquine,antioxidants such as palmityl-6-L-ascorbic acid, tocopherols and alpha-tocopherol, propyl gallate, buthylhydroxyanisol (BHA), butylated hydroxytoluene (BHT) and ethoxyquin,

- les caroténoïdes et xanthophyles tels que les béta-carotènes, la capsanthine, la taurine, la lutéine, la zéaxanthine, la citranaxanthine et l’astaxanthine,carotenoids and xanthophyls such as beta-carotenes, capsanthin, taurine, lutein, zeaxanthin, citranaxanthin and astaxanthin,

- les polyphénols dont les flavonoïdes telq que la flavone, le flavonol, la flavonone, le dihydroflavonol, l’isoflavone, l’isoflavanone, la chalone, l’aurone, l’anthocyanes, les tanins, la quercetine, le cyanidol, le delphinidol et le malvidol, polyphenols including flavonoids such as flavone, flavonol, flavonone, dihydroflavonol, isoflavone, isoflavanone, chalone, aurone, anthocyanin, tannins, quercetin, cyanidol, delphinidol and malvidol,

- les vitamines et provitamines telles que l’acide palmityl-6-L-ascorbique, la vitamine E, l’acétate d’alphatocophéryle et l’acide folique, vitamins and provitamines such as palmityl-6-L-ascorbic acid, vitamin E, alphatocopheryl acetate and folic acid,

- les oligo-éléments : le cuivre, le manganèse, le zinc, le sélénium (forme organique) et le fer, trace elements: copper, manganese, zinc, selenium (organic form) and iron,

- et les extraits végétaux riches en agents antioxydants,  tels que les extraits de gingembre, de sauge, de citrus, de romarin, de girofle, de pépins et/ou de peau de raisin, de thym, et de curcuma. - and plant extracts rich in antioxidants, such as extracts of ginger, sage, citrus, rosemary, clove, seeds and / or grape skin, thyme, and turmeric.

Ces listes ne sont pas limitatives et l’homme du métier saura choisir le ou les composés antioxydants additionnels appropriés.These lists are not limiting and one skilled in the art will be able to choose the appropriate additional antioxidant compound (s).

Il existe par ailleurs des produits antioxydants commerciaux, naturels ou de synthèse, qui peuvent contenir plusieurs additifs voire matières premières, dont au moins un a une activité antioxydante.In addition, there are commercial antioxidant products, natural or synthetic, which can contain several additives or even raw materials, at least one of which has antioxidant activity.

En temps normal, il existe un équilibre entre la production permanente de radicaux libres dans l’organisme et les systèmes de défense, les antioxydants. Le stress oxydatif est une rupture de cet équilibre (déficit en antioxydants et/ou surproduction de radicaux libres) et est susceptible d’entraîner une immunodépression chez l’animal. Ce déséquilibre peut être induit par des défaillances nutritionnelles et/ou des carences en antioxydants, voire dans certains cas, par des excès en antioxydants. Normally, there is a balance between the permanent production of free radicals in the body and the defense systems, the antioxidants. Oxidative stress is a break in this balance (lack of antioxidants and / or overproduction of free radicals) and is likely to cause immunodepression in animals. This imbalance can be induced by nutritional failures and / or deficiencies in antioxidants, and in some cases by excessive antioxidants.

Lorsqu'un animal est exposé à un stress, la production de radicaux libres augmente et ses réserves antioxydantes diminuent, ceci conduisant à un stress oxydatif. Chez l’animal, le stress oxydatif peut apparaitre au cours de certaines phases critiques et notamment à l’occasion de déséquilibres alimentaires : niveaux d’alimentation élevés, restriction alimentaire, consommation de xénobiotiques ou de toxines, carence en micronutriments, manque en nutriments précurseurs d’antioxydants (principalement vitamine E, B-carotène, sélénium, cuivre et zinc), désordres métaboliques liés à un déficit énergétique important… ; ou de certains stades physiologiques : période péri-partum, gestation (mère et fœtus), période néonatale. L’apparition du stress oxydatif est également dépendant des conditions d’élevage : variations climatiques, stress émotionnel (confinement, transport, stress ante mortem) ; de l’état sanitaire de l’animal ou encore lié à une activité métabolique intense : production de grande quantité de lait chez la vache laitière.When an animal is exposed to stress, the production of free radicals increases and its antioxidant reserves decrease, leading to oxidative stress. In the animal, the oxidative stress can appear during certain critical phases and in particular at the time of food imbalances: high food levels, food restriction, consumption of xenobiotics or toxins, micronutrient deficiency, lack of precursor nutrients antioxidants (mainly vitamin E, B-carotene, selenium, copper and zinc), metabolic disorders linked to a significant energy deficit ...; or certain physiological stages: peri-partum period, gestation (mother and fetus), neonatal period. The onset of oxidative stress is also dependent on rearing conditions: climatic variations, emotional stress (confinement, transport, ante-mortem stress); the animal's health status or linked to intense metabolic activity: production of large quantities of milk in dairy cows.

Le stress oxydatif se traduit chez l’animal par une stimulation des enzymes intervenant dans sa régulation (glutathion peroxydase, superoxyde dismutase, catalase), une oxydation des antioxydants de l’organisme (glutathion, protéines thiols, vitamines E, C, A), et l’accumulation des produits d’oxydation. La première conséquence pour l’organisme est l’apparition de dégâts souvent irréversibles pour la cellule. Plus largement, le stress oxydatif peut avoir des conséquences sur la qualité des produits mais aussi sur la santé des animaux.Oxidative stress is expressed in animals by stimulation of the enzymes involved in its regulation (glutathione peroxidase, superoxide dismutase, catalase), oxidation of antioxidants in the body (glutathione, thiol proteins, vitamins E, C, A), and the accumulation of oxidation products. The first consequence for the body is the appearance of often irreversible damage to the cell. More broadly, oxidative stress can affect not only product quality but also animal health.

Avantageusement, l’invention concerne la composition susmentionnée, où ledit au moins un agent antioxydant additionnel représente en masse, jusqu’à 2% par rapport à la masse totale de la composition.Advantageously, the invention relates to the abovementioned composition, wherein said at least one additional antioxidant agent represents, by weight, up to 2% relative to the total mass of the composition.

Dans l’invention, le ou les agents antioxydants additionnels contenus dans la composition représentent en masse par rapport à la masse totale de la composition 0%, 0,1%, 0,2%, 0,3%, 0,4%, 0,5%, 0,6%, 0,7%, 0,8%, 0,9%, 1%, 1,1%, 1,2%, 1,3%, 1,4%, 1,5%, 1,6%, 1,7%, 1,8%, 1,9% ou 2%.In the invention, the additional antioxidant agent (s) contained in the composition represent, by weight relative to the total mass of the composition, 0%, 0.1%, 0.2%, 0.3%, 0.4%, 0.5%, 0.6%, 0.7%, 0.8%, 0.9%, 1%, 1.1%, 1.2%, 1.3%, 1.4%, 1, 5%, 1.6%, 1.7%, 1.8%, 1.9% or 2%.

De manière avantageuse, l’invention concerne la composition susmentionnée, comprenant en outre au moins un support.Advantageously, the invention relates to the aforementioned composition, further comprising at least one support.

Outre la bétaïne et au moins un antioxydant, c’est-à-dire au moins l’acide ascorbique, et la matrice cristalline de lipides hydrogénés, il est possible, lors de la fabrication de la composition de l’invention, d’ajouter un ou plusieurs support décrits ci-après. Ces supports ont pour effet de stabiliser et de solidifier la composition et notamment de permettre de solidifier la matrice cristalline de lipides hydrogénés.In addition to betaine and at least one antioxidant, that is to say at least ascorbic acid, and the crystalline matrix of hydrogenated lipids, it is possible, during the manufacture of the composition of the invention, to add one or more supports described below. These supports have the effect of stabilizing and solidifying the composition and in particular to allow solidification of the crystalline matrix of hydrogenated lipids.

Ledit au moins un support est choisi parmi la silice, le carbonate de calcium, la silice pyrogène, le stéarate de calcium, le stéarate de magnésium et le sulfate de calcium, le formiate de calcium, la bentonite, le phosphate calcique, le dextrose ou un mélange de ceux-ci.Said at least one support is chosen from silica, calcium carbonate, pyrogenic silica, calcium stearate, magnesium stearate and calcium sulphate, calcium formate, bentonite, calcium phosphate, dextrose or a mixture of these.

Une composition avantageuse selon l’invention est constituée, en masse par rapport à la masse totale de ladite composition de : An advantageous composition according to the invention consists, in mass with respect to the total mass of said composition of:

38% d’huile de colza hydrogénée,38% hydrogenated rapeseed oil,

7,05% de silice,7.05% silica,

5% de sulfate de calcium anhydre,5% anhydrous calcium sulphate,

42% de bétaïne anhydre à 96%, et42% betaine anhydrous at 96%, and

7,95% de vitamine C à 97,5%.7.95% of vitamin C to 97.5%.

Avantageusement, une autre composition selon l’invention est constituée, en masse par rapport à la masse totale de ladite composition de :Advantageously, another composition according to the invention consists, in mass with respect to the total mass of said composition of:

50% d’huile de palme hydrogénée,50% hydrogenated palm oil,

11,7% de silice,11.7% silica,

5% de sulfate de calcium anhydre,5% anhydrous calcium sulphate,

28% de bétaïne anhydre à 96%, et28% betaine anhydrous at 96%, and

5,3% de vitamine C à 97,5%,5.3% of vitamin C at 97.5%,

Avantageusement, une autre composition selon l’invention est constituée, en masse par rapport à la masse totale de ladite composition de :Advantageously, another composition according to the invention consists, in mass with respect to the total mass of said composition of:

50% d’huile de palme hydrogénée,50% hydrogenated palm oil,

10,4% de carbonate de calcium,10.4% calcium carbonate,

5% de sulfate de calcium anhydre,5% anhydrous calcium sulphate,

28% de bétaïne anhydre à 96%,28% betaine anhydrous at 96%,

5,3% de vitamine C à 97,5%, et5.3% of vitamin C at 97.5%, and

1,3% de vitamine E1.3% of vitamin E

Encore une autre composition avantageuse de l’invention est constituée, en masse par rapport à la masse totale de ladite composition de :Yet another advantageous composition of the invention consists, in mass with respect to the total mass of said composition of:

50% d’huile de palme hydrogénée,50% hydrogenated palm oil,

10,4% de silice,10.4% silica,

5% de sulfate de calcium anhydre,5% anhydrous calcium sulphate,

5,3% de vitamine C à 97,5%,5.3% of vitamin C at 97.5%,

0,8% d’extrait de pépins de raisin, 0.8% grape seed extract,

28% de bétaïne anhydre à 96%, et28% betaine anhydrous at 96%, and

0,5% d’un prémélange d’acide folique (0,1% d’acide folique à 92% déposé sur un support, par rapport à la masse totale du prémélange)0.5% of a folic acid premix (0.1% of 92% folic acid on a carrier, based on the total mass of the premix)

Encore une autre composition avantageuse de l’invention est constituée, en masse par rapport à la masse totale de ladite composition de :Yet another advantageous composition of the invention consists, in mass with respect to the total mass of said composition of:

50% d’huile de palme hydrogénée,50% hydrogenated palm oil,

15,6% silice,15.6% silica,

5,5,% de vitamine C à 97,5%,5.5% of vitamin C at 97.5%,

28% de bétaïne anhydre à 96%,28% betaine anhydrous at 96%,

0,55% vitamine E, et 0.55% vitamin E, and

0,35% d’extrait de curcuma0.35% turmeric extract

Une autre composition avantageuse de l’invention est constituée, en masse par rapport à la masse totale de ladite composition de :Another advantageous composition of the invention consists, in mass with respect to the total mass of said composition of:

62,7% d’huile de palme hydrogénée,62.7% hydrogenated palm oil,

15% de silice,15% silica,

5% de sulfate de calcium anhydre,5% anhydrous calcium sulphate,

2,65% de vitamine C à 97,5%,2.65% of vitamin C at 97.5%,

14% de bétaïne anhydre à 96%,14% betaine anhydrous at 96%,

0,4% d’extrait de vitamine E, et0.4% vitamin E extract, and

0,25% d’un prémélange d’acide folique (0,1% d’acide folique à 92% déposé sur un support, par rapport à la masse totale du prémélange)0.25% of a folic acid premix (0.1% 92% folic acid on a carrier, based on the total weight of the premix)

L’invention concerne en outre un aliment destiné à la nutrition des animaux d’élevages comprenant de 0,05% à 0,2% en masse d’une composition telle que définie précédemment par rapport à la masse totale de l’aliment.The invention furthermore relates to a feed intended for the nutrition of farm animals comprising from 0.05% to 0.2% by weight of a composition as defined above with respect to the total mass of the feed.

La composition susmentionnée peut être ajoutée en tant que complément ou additif à de l’alimentation animale dans des proportions variant de 500g à 2kg par tonne d’aliment. De telles proportions représentent de 0,05% à 0,2% en masse de composition par rapport à la masse totale de l’aliment. Cela signifie que la composition représente, en masse, par rapport à la masse totale de l’aliment, 0,05%, 0,06%, 0,07%, 0,08%, 0,09%, 0,1%, 0,11%, 0,12%, 0,13%, 0,14%, 0,15%, 0,16%, 0,17%, 0,18%, 0,19% ou 0,2%.The aforementioned composition can be added as a supplement or additive to animal feed in proportions ranging from 500g to 2kg per ton of feed. Such proportions represent from 0.05% to 0.2% by weight of composition relative to the total weight of the food. This means that the composition represents, in mass, relative to the total mass of the food, 0.05%, 0.06%, 0.07%, 0.08%, 0.09%, 0.1% , 0.11%, 0.12%, 0.13%, 0.14%, 0.15%, 0.16%, 0.17%, 0.18%, 0.19% or 0.2% .

L’invention concerne par ailleurs un procédé de préparation d’une composition telle que définie précédemment, comprenant les étapes suivantes :The invention also relates to a method for preparing a composition as defined above, comprising the following steps:

a) la mise en contact d’un ou plusieurs lipides hydrogénés ayant une température de fusion de 55°C à 80°C, notamment de l’huile hydrogénée ayant une température de fusion de 55°C à 80°C, avec de l’acide ascorbique et de la bétaïne, ledit un ou plusieurs lipides hydrogénés étant portés à une température au moins égale à la température de fusion dudit un ou plusieurs lipides hydrogénés de sorte que ce ou ces derniers soient sous forme liquide ou pâteuse, la forme pâteuse correspondant à un mélange de lipides fondus et de lipides encore solides,a) contacting one or more hydrogenated lipids having a melting point of 55 ° C to 80 ° C, especially hydrogenated oil having a melting temperature of 55 ° C to 80 ° C, with ascorbic acid and betaine, said one or more hydrogenated lipids being brought to a temperature at least equal to the melting temperature of said one or more hydrogenated lipids so that these or these are in liquid or pasty form, the pasty form corresponding to a mixture of molten lipids and still solid lipids,

b) le mélange, notamment homogène, des composés mis en contact à l’étape précédente, cette étape ayant lieu pendant un intervalle de temps suffisant pour que la température de la mixture issue du dudit mélange homogène redescende à une température inférieure à la température de cristallisation dudit un ou plusieurs lipides hydrogénés pour obtenir une matrice cristalline essentiellement constituée d’un ou plusieurs lipides hydrogénés dans laquelle sont dispersés de l’acide ascorbique et de la bétaïne.b) the mixture, especially homogeneous, of the compounds contacted in the previous step, this step taking place for a period of time sufficient for the temperature of the mixture from said homogeneous mixture to drop to a temperature below the temperature of crystallizing said one or more hydrogenated lipids to obtain a crystalline matrix consisting essentially of one or more hydrogenated lipids in which are dispersed ascorbic acid and betaine.

La composition selon l’invention est donc préparée selon un procédé simple mettant à profit les propriétés de cristallisation des lipides et leur température de fusion et de cristallisation.The composition according to the invention is thus prepared according to a simple process making use of the crystallization properties of lipids and their melting and crystallization temperature.

Dans l’invention, on entend par «le mélange homogène », l’action de mélanger  les différents constituants de la composition de sorte qu’ils soient répartis de manière quasi -uniforme ou uniforme.In the invention, the term "the homogeneous mixture", the action of mixing the various constituents of the composition so that they are distributed in a substantially uniform or uniform manner.

Afin de réaliser la composition selon l’invention, ledit un ou plusieurs lipides hydrogénés sont chauffés à une température allant au-delà du point de fusion (température de fusion) du ou des lipides tels que définis précédemment. Ledit lipide ou lesdits lipides sont alors sous forme liquide ou sous forme pâteuse.In order to produce the composition according to the invention, said one or more hydrogenated lipids are heated to a temperature that goes beyond the melting point (melting temperature) of the lipid (s) as defined above. Said lipid or lipids are then in liquid form or in pasty form.

Il est alors possible d’ajouter les composés actifs (bétaïne et acide ascorbique) aux lipides sous forme liquide ou pâteuse. Afin de réaliser une dispersion uniforme ou non, le mélange lipides/bétaïne/acide ascorbique est mélangé par tout moyen de mélange ou brassage (pilons, spatules, pales, hélices...). La température du mélange, et en particulier la température du ou des lipides, va alors diminuer progressivement jusqu’à, dans un premier temps, descendre sous la température de fusion des lipides fondus. Si le mélange est toujours brassé (ou soumis à mélange), la température va diminuer en dessous du point de cristallisation du ou desdits lipides induisant ainsi une cristallisation de ce ou de ces derniers.It is then possible to add the active compounds (betaine and ascorbic acid) to lipids in liquid or pasty form. In order to achieve uniform dispersion or not, the lipid / betaine / ascorbic acid mixture is mixed by any means of mixing or mixing (pestles, spatulas, blades, propellers ...). The temperature of the mixture, and in particular the temperature of the lipid or lipids, will then gradually decrease until, at first, it falls below the melting temperature of the molten lipids. If the mixture is still stirred (or subjected to mixing), the temperature will decrease below the point of crystallization of said lipid or said inducing a crystallization of this or these.

C’est ainsi, par un refroidissement progressif sous agitation, que le ou les lipides hydrogénés vont progressivement cristalliser et, du fait de l’agitation, former des cristaux au milieu desquels la bétaïne et l’acide ascorbique seront finement dispersés, de manière homogène ou non.Thus, by progressive cooling with stirring, the hydrogenated lipid (s) will gradually crystallize and, because of the agitation, form crystals in the middle of which betaine and ascorbic acid will be finely dispersed, homogeneously or not.

Les températures de fusion et de cristallisation des huiles avantageuses sont décrites ci-dessus. The melting and crystallization temperatures of the advantageous oils are described above.

Par exemple, une composition selon l’invention réalisée à partir d’huile de colza raffinée et hydrogénée sera obtenue selon le procédé suivant : For example, a composition according to the invention made from refined and hydrogenated rapeseed oil will be obtained according to the following process:

L’huile de colza hydrogénée et raffinée est chauffée à une température au-dessus de 68°C (point de fusion) afin d’obtenir une huile liquide.The refined hydrogenated rapeseed oil is heated to a temperature above 68 ° C (melting point) to obtain a liquid oil.

De la bétaïne et de l’acide ascorbique à température ambiante sont ajouté à l’huile liquide, et le mélange est placé sous agitation.Betaine and ascorbic acid at room temperature are added to the liquid oil, and the mixture is stirred.

L’agitation est réalisée pendant un temps suffisant pour que la température du mélange atteigne une température inférieure à 49°C (température de cristallisation) afin de permettre une cristallisation lente et progressive. Stirring is carried out for a time sufficient for the temperature of the mixture to reach a temperature below 49 ° C. (crystallization temperature) in order to allow slow and gradual crystallization.

En fin de procédé, des cristaux d’huile de colza raffinée et hydrogénée se sont formés et la bétaïne et l’acide ascorbique se retrouvent dispersés de manière homogène ou non entre les cristaux.At the end of the process, crystals of refined and hydrogenated rapeseed oil have formed and betaine and ascorbic acid are found dispersed homogeneously or otherwise between the crystals.

Le mélange peut être réalisé par un mélangeur classique connu de l’homme de métier.The mixing can be carried out by a conventional mixer known to those skilled in the art.

Si la composition comprend des composés supplémentaires (autres que la bétaïne et l’acide ascorbique), ces composés sont ajoutés aux lipides fondus ou sous forme pâteuse, en même temps que la bétaîne et l’acide ascorbique.If the composition comprises additional compounds (other than betaine and ascorbic acid), these compounds are added to the molten lipids or in pasty form, together with betaine and ascorbic acid.

L’invention concerne par ailleurs une composition comprenant de l’acide ascorbique et de la bétaïne dispersés de manière homogène ou non dans une matrice cristalline essentiellement constituée d’un ou plusieurs lipides hydrogénés susceptible d’être obtenue, ou obtenue directement, par le procédé susmentionné.The invention furthermore relates to a composition comprising ascorbic acid and betaine dispersed in a homogeneous or non-homogeneous manner in a crystalline matrix consisting essentially of one or more hydrogenated lipids that can be obtained, or obtained directly, by the process above.

L’invention concerne en outre une composition telle que définie ci-dessus, ou un aliment tel que défini ci-dessus, pour son utilisation pour la protection contre les effets du stress thermique des animaux monogastriques, notamment les volailles ou les porcins d’élevage.The invention furthermore relates to a composition as defined above, or a food as defined above, for its use for the protection against the effects of heat stress of monogastric animals, especially poultry or farmed pigs. .

Il est entendu dans l’invention qu’un animal monogastrique correspond à tout animal qui ne vit pas à l’état sauvage. Par « animaux monogastriques », on entend donc les animaux monogastriques élevés dans le but d’une production animale ou de conservation, ainsi que les animaux domestiques.It is understood in the invention that a monogastric animal corresponds to any animal that does not live in the wild. "Monogastric animals" means monogastric animals raised for the purpose of animal production or conservation, as well as domestic animals.

Chez les animaux homéothermes, dans la zone de confort thermique, l’homéothermie est maintenue grâce à des mécanismes peu coûteux en énergie (comportement plus calme, pertes sensibles par radiation, conduction ou convection de la chaleur). Au-delà de cette zone, les pertes de chaleur par la voie sensible diminuent et l’homéothermie est assurée uniquement par une augmentation importante des pertes par voie latente (évaporation et/ou perspiration).In homeothermic animals, in the thermal comfort zone, homeothermy is maintained by means of inexpensive energy mechanisms (quieter behavior, sensible radiation losses, conduction or convection of heat). Beyond this zone, heat losses through the sensitive pathway decrease and homeothermy is ensured only by a significant increase in latent losses (evaporation and / or perspiration).

La zone de thermoneutralité est définie par des températures ambiantes critiques inférieures et supérieures qui dépendent de nombreux critères : espèce, stade physiologique, sexe, niveau d’emplument pour les volailles, vitesse de croissance, niveau de production… mais aussi des facteurs du milieu : humidité relative, habitat, ...The thermoneutrality zone is defined by lower and higher critical ambient temperatures which depend on many criteria: species, physiological stage, sex, level of use for poultry, speed of growth, level of production ... but also environmental factors: relative humidity, habitat, ...

Les transferts qui s’établissent dans cette gamme de température correspondent à des dépenses énergétiques faibles, non influencées par l’environnement et égales à la production de chaleur alors due aux besoins vitaux et à la transformation de l’aliment en muscle et graisse. Le confort thermique de l’animal y est optimal. Les animaux d’élevage y transforment efficacement leur ration afin de produire (œuf, viande, lait, ...) Plus simplement, cette zone de thermoneutralité correspond à une gamme de température au sein de laquelle l’animal n’utilise pas ou peu d’énergie pour réguler sa température.The transfers that occur in this temperature range correspond to low energy expenditure, not influenced by the environment and equal to the production of heat then due to the vital needs and the transformation of the food into muscle and fat. The thermal comfort of the animal is optimal. Farm animals effectively transform their ration in order to produce (egg, meat, milk, ...) More simply, this zone of thermoneutrality corresponds to a temperature range in which the animal uses little or no of energy to regulate its temperature.

Ainsi, au-delà de cette zone de thermoneutralité, on observe que la perte de chaleur par radiation et contact devient limitante chez l’animal et que la perte de chaleur par évapotranspiration prend une importance croissante. Chez les oiseaux, les glandes sudoripares absentes ou peu efficientes jouent un rôle négligeable dans la thermorégulation. Les pertes de chaleur par évapotranspiration ont alors lieu sur les surfaces muqueuses pulmonaires. Thus, beyond this zone of thermoneutrality, it is observed that the heat loss by radiation and contact becomes limiting in the animal and that the heat loss by evapotranspiration takes on increasing importance. In birds, absent or inefficient sweat glands play a negligible role in thermoregulation. Heat loss by evapotranspiration then takes place on the pulmonary mucosal surfaces.

Chez le porc, tout comme pour les volailles, en l’absence de sudation (glandes sudoripares absentes ou non fonctionnelles), une température élevée va provoquer une hyperventilation respiratoire, qui a finalement peu de conséquence sur l’équilibre acido-basique du sang. Le porc ajuste ses fonctions cardiovasculaires par une augmentation du flux sanguin au niveau sous-cutané et au niveau du système respiratoire, et par une diminution du flux vers les tissus fortement producteurs de chaleurs tels que le foie, les muscles ou le tube digestif. On observe également une modification de la température cutanée, une amélioration des pertes de chaleur par radiation et convection liée à l’augmentation de la vasodilatation des artérioles sous-cutanées.In pigs, as in poultry, in the absence of sweating (sweat glands absent or non-functional), high temperature will cause respiratory hyperventilation, which ultimately has little effect on the acid-base balance of the blood. Pork adjusts cardiovascular function by increasing blood flow to the subcutaneous and respiratory systems, and by decreasing the flow to highly heat-producing tissues such as the liver, muscles or digestive tract. There is also a change in skin temperature, an improvement in heat loss by radiation and convection related to the increase in vasodilation of subcutaneous arterioles.

Un stress thermique chez le porc affecte également, de manière conséquente, le comportement alimentaire des porcs : moindre consommation (diminution de la taille des repas couplée à une réduction du nombre de repas à certains stades physiologiques, seul moyen de maintenir l’homéothermie), transfert des repas vers les périodes fraîches de la journée. Ces impacts sur le comportement alimentaire ont des effets supplémentaires chez la truie : déficit nutritionnel, mobilisation des réserves pour maintenir la croissance des porcelets et la production de lait. Chez le porc en croissance, on observe une réduction de la vitesse de croissance, une augmentation du taux de viande maigre dans les carcasses.Heat stress in pigs also significantly affects the feeding behavior of pigs: lower consumption (reduced size of meals coupled with a reduction in the number of meals at certain physiological stages, the only way to maintain homeothermia), transfer of meals to the cooler times of the day. These impacts on feeding behavior have additional effects on the sow: nutritional deficit, mobilization of reserves to maintain piglet growth and milk production. In growing pigs, there is a reduction in growth rate, an increase in lean meat in carcasses.

Une température élevée augmente les pertes en eau, peut perturber les équilibres électrolytiques mais peut également augmenter l’oxydation cellulaire. High temperature increases water losses, can disturb electrolyte balance but can also increase cell oxidation.

Les effets négatifs d’un stress thermique chez les animaux homéothermes, et notamment les volailles et les porcs, n’affectent pas seulement la prise alimentaire et la croissance, mais également le rendement en carcasse et le taux de survie.The negative effects of heat stress in warm-blooded animals, especially poultry and pigs, do not only affect feed intake and growth, but also carcass yield and survival.

La composition selon l’invention a pour but de remédier à ces inconvénientsThe composition according to the invention aims to remedy these disadvantages

L’invention concerne par ailleurs l’utilisation d’une composition telle que définie ci-dessus, pour la fabrication d’un produit pharmaceutique ou vétérinaire, destiné à la protection contre les effets du stress thermique des animaux monogastriques d’élevage, notamment les volailles ou les porcins.The invention furthermore relates to the use of a composition as defined above, for the manufacture of a pharmaceutical or veterinary product, intended for protection against the effects of thermal stress on farmed monogastric animals, especially the poultry or swine.

Il est par ailleurs décrit une méthode de protection contre les effets du stress thermique des animaux monogastriques, ladite méthode comprenant l’administration à des animaux monogastriques, notamment des volailles ou des porcins d’élevage, dans le besoin, ou susceptible d’être dans le besoin, une dose efficace d’une composition telle que définie précédemment.In addition, a method for protecting against the effects of thermal stress on monogastric animals is described, said method comprising the administration to monogastric animals, in particular farmed poultry or pigs, in need, or likely to be in the need, an effective dose of a composition as defined above.

La figure 1 représente des histogrammes montrant l’activité de l’enzyme plasmatique créatine-kinase de poulets de chair à 34j, exprimée en unité/litre, pour chacun des groupes étudiés : (1) : Lot témoin négatif sans apport de bétaïne (gris foncé) ; (2) : Lot avec apport de bétaïne anhydre de synthèse 96% non vectorisée à 500 ppm (gris) ; (3) : Lot avec apport en bétaïne anhydre de synthèse 96% vectorisée à 500 ppm (gris clair). FIG. 1 represents histograms showing the activity of the plasma creatine kinase enzyme of 34J chickens, expressed in units / liter, for each of the groups studied: (1): Negative control batch without betaine (gray) dark); (2) Lot with betaine supply of synthetic anhydrous 96% non-vectorized at 500 ppm (gray); (3): batch with betaine anhydrous synthetic 96% vectorized at 500 ppm (light gray).

La figure 2 représente des histogrammes montrant l’activité de l’enzyme Glutathion Peroxydase (GPx) de poulets de chair à 34j, exprimée en unité/litre, pour chacun des groupes étudiés : (1) : Lot témoin négatif sans apport de bétaïne (gris foncé) ; (2) : Lot avec apport de bétaïne anhydre de synthèse 96% non vectorisée à 500 ppm (gris) ; (3) : Lot avec apport en bétaïne anhydre de synthèse 96% vectorisée à 500 ppm (gris clair). FIG. 2 represents histograms showing the activity of the 34 mg broiler Glutathione Peroxidase (GPx) enzyme, expressed in units / liter, for each of the groups studied: (1): Negative control batch without betaine supply ( dark gray) ; (2) Lot with betaine supply of synthetic anhydrous 96% non-vectorized at 500 ppm (gray); (3): batch with betaine anhydrous synthetic 96% vectorized at 500 ppm (light gray).

La figure 3 représente des histogrammes montrant l’indice de consommation corrigé du poids de poulets de chair, exprimé en g/g, sur la période 21-34j pour chacun des groupes étudiés : (1) : Lot témoin négatif sans apport de bétaïne (gris foncé) ; (2) : Lot avec apport de bétaïne anhydre de synthèse 96% non vectorisée à 500 ppm (gris) ; (3) : Lot avec apport en bétaïne anhydre de synthèse 96% vectorisée à 500 ppm (gris clair). FIG. 3 represents histograms showing the corrected consumption index of the weight of broilers, expressed in g / g, over the period 21-34j for each of the groups studied: (1): Negative control batch without betaine supply ( dark gray) ; (2) Lot with betaine supply of synthetic anhydrous 96% non-vectorized at 500 ppm (gray); (3): batch with betaine anhydrous synthetic 96% vectorized at 500 ppm (light gray).

La figure 4 représente des histogrammes montrant le Gain Moyen Quotidien (GMQ) de poulets de chair, exprimé en g/jour, sur la période 21-34j, pour chacun des groupes étudiés : (1) : Lot témoin négatif sans apport de bétaïne (gris foncé) ; (2) : Lot avec apport de bétaïne anhydre de synthèse 96% non vectorisée à 500 ppm (gris) ; (3) : Lot avec apport en bétaïne anhydre de synthèse 96% vectorisée à 500 ppm (gris clair). FIG. 4 represents histograms showing the Daily Average Gain (GMQ) of broilers, expressed in g / day, over the period 21-34j, for each of the groups studied: (1): Negative control batch without betaine supply ( dark gray) ; (2) Lot with betaine supply of synthetic anhydrous 96% non-vectorized at 500 ppm (gray); (3): batch with betaine anhydrous synthetic 96% vectorized at 500 ppm (light gray).

La figure 5 représente des courbes montrant l’évolution du poids moyen de poulets de chair, exprimé en % du groupe témoin (1), sur la période 7-42j pour chacun des groupes étudiés : (1) : Lot témoin négatif (points noirs) ; (2) : Lot avec apport de vitamine C et autres antioxydants non vectorisés (points gris clair) ; (3) : Lot avec apport de la composition selon l’invention (triangle gris foncé). FIG. 5 shows curves showing the evolution of the average broiler weight, expressed in% of the control group (1), over the period 7-42j for each of the groups studied: (1): Negative control lot (black spots ); (2): Batch with vitamin C and other non-vectorized antioxidants (light gray dots); (3): Lot with contribution of the composition according to the invention (dark gray triangle).

La figure 6 représente un histogramme comparant l’indice de consommation de poulets de chair, exprimé en % du groupe témoin (1), sur la période 0-45j pour chacun des groupes étudiés : (1) : Lot témoin négatif (noir) ; (2) : Lot avec apport de vitamine C et autres antioxydants non vectorisés (gris foncé) ; (3) : Lot avec apport de la composition selon l’invention (gris clair). FIG. 6 represents a histogram comparing the index of consumption of broilers, expressed in% of the control group (1), over the period 0-45j for each of the groups studied: (1): negative control lot (black); (2): Batch with vitamin C and other non-vectorized antioxidants (dark gray); (3): batch with contribution of the composition according to the invention (light gray).

La figure 7 représente un histogramme montrant l’indice de consommation corrigé du poids (ICC) de poulets de chair à 37j, exprimé en g/g, pour chacun des groupes étudiés : (1) : Lot témoin négatif sans supplémentation en bétaïne ni antioxydant (gris foncé) ; (2) : Lot avec apport de bétaïne HCl de synthèse 95% non vectorisée permettant un apport de 700ppm de bétaïne pure (gris) ; (3) : Lot avec apport de bétaïne HCl de synthèse 95% vectorisée avec de l’huile de palme hydrogénée permettant un apport de 350ppm de bétaïne pure (gris clair) ; (4) : Lot avec apport de la composition selon l’invention permettant un apport de 200 ppm de bétaïne pure (rayures). FIG. 7 represents a histogram showing the weight-corrected consumption index (ICC) of broilers at 37j, expressed in g / g, for each of the groups studied: (1): Negative control batch without betaine supplementation or antioxidant (dark gray) ; (2): Lot with betaine HCl synthetic 95% non-vectorized allowing a contribution of 700ppm pure betaine (gray); (3): Batch of betaine HCl synthetic 95% vectorized with hydrogenated palm oil allowing a supply of 350ppm pure betaine (light gray); (4): batch with contribution of the composition according to the invention for a supply of 200 ppm of pure betaine (scratches).

La figure 8 représente un histogramme montrant les poids des filets de poulets de chair, exprimés en g, sur la période 0-36j pour chacun des groupes étudiés : (1) : Lot témoin négatif sans supplémentation en bétaïne ni antioxydant (gris foncé) ; (2) : Lot avec apport de bétaïne HCl de synthèse 95% non vectorisée permettant un apport de 700ppm de bétaïne pure (gris) ; (3) : Lot avec apport de bétaïne HCl de synthèse 95% vectorisée avec de l’huile de palme hydrogénée permettant un apport de 350ppm de bétaïne pure (gris clair) ; (4) : Lot avec apport de la composition selon l’invention permettant un apport de 200 ppm de bétaïne pure (rayures). Figure 8 represents a histogram showing the weight of the fillets of broilers, expressed in g, the 0-36j period for each of the groups studied: (1): Lot negative control without supplementation betaine or antioxidant (dark gray); (2): Lot with betaine HCl synthetic 95% non-vectorized allowing a contribution of 700ppm pure betaine (gray); (3): Batch of betaine HCl synthetic 95% vectorized with hydrogenated palm oil allowing a supply of 350ppm pure betaine (light gray); (4): batch with contribution of the composition according to the invention for a supply of 200 ppm of pure betaine (scratches).

EXEMPLESEXAMPLES

Exemple 1Example 1 : Effets d'une supplémentation en : Effects of supplementation bétaïnebetaine et en antioxydants alimentaires  and in food antioxidants vectorisés vectorized sur les performances de croissance, le stress oxydatif et la qualité de la carcasse de poulets de chair maintenus à des températures élevéeson growth performance, oxidative stress and carcass carcass quality maintained at high temperatures

Les performances de croissance des poulets de chair et le rendement en viande sont altérés par une température élevée.The growth performance of broilers and the meat yield are altered by high temperature.

Cette déficience est imputable à une réduction de la consommation alimentaire et à une augmentation du stress oxydatif, ce qui induit une hémolyse et une qualité moindre de la carcasse. La supplémentation en bétaïne peut réduire ces effets négatifs grâce à ses propriétés osmoprotectrices et à son rôle de donneur de méthyl. De plus, la vitamine C et d'autres antioxydants peuvent protéger contre le stress oxydatif et l'hémolyse. La bétaïne et les vitamines étant des principes actifs agressifs ou sensibles, un processus de vectorisation spécifique avec une matière grasse végétale sélectionnée a été appliqué. Le but de cette étude était d'évaluer l'effet de la composition selon l’invention sur les performances de croissance, la qualité de la carcasse et l'hémolyse sanguine chez des poulets de chair élevés en conditions chaudes. Au total, 192 poulets de chair mâles Ross 308 ont été répartis dans un bloc complet randomisé comprenant 3 groupes: T- (témoin négatif, pas de composition selon l’invention), B1 (T- + 750 g / Tonne de composition selon l’invention) et B2 (T- + 1300 g / Tonne de composition selon l’invention), chacun répété 16 fois avec 4 oiseaux par cage. Du jour 21 au jour 35, la température a été modifiée quotidiennement pour simuler des températures estivales élevées pouvant atteindre 30 °C. La performance de croissance a été mesurée pendant toute l'expérience. À 36 jours, les oiseaux ont été abattus. Les marqueurs plasmatiques du stress oxydatif, ainsi que le statut d'hémolyse sanguine, ont été comparés entre T- et B2. La perte en eau et le rendement filets ont été comparés. Les données ont été analysées à l’aide d’une analyse de variance univariée et du test de Tukey en tant que test post-hoc. La composition selon l’invention testée en B1 et B2 a eu un effet significatif sur la prise de poids corporel, la consommation et l'efficacité alimentaire entre 0 et 36 jours (P<0,05). Une analyse post-hoc a révélé que B1 donnait les meilleurs résultats pour les paramètres susmentionnés (P<0,05). Le rendement filets a été significativement augmenté par la supplémentation via la composition selon l’invention, et encore plus pour B1 (P<0,01). Les marqueurs de stress oxydatif n'étaient pas significativement affectés par une intervention alimentaire. De plus, B2 présentait un score d'hémolyse inférieur à celui de T- (4,12 g / L vs 4,44 g / L, p<0,05). Ces résultats indiquent que la composition selon l’invention a un effet positif sur les performances de croissance et l'intégrité des érythrocytes des poulets de chair, montrant une meilleure résistance lorsque l'environnement thermique dépasse la zone de thermoneutralité des animaux.This deficiency is attributable to a reduction in food consumption and an increase in oxidative stress, which leads to hemolysis and a lower quality of the carcass. Betaine supplementation can reduce these negative effects by virtue of its osmoprotective properties and its role as a methyl donor. In addition, vitamin C and other antioxidants can protect against oxidative stress and hemolysis. Since betaine and vitamins are aggressive or sensitive active ingredients, a specific vectorization process with a selected vegetable fat has been applied. The purpose of this study was to evaluate the effect of the composition according to the invention on growth performance, carcass quality and blood hemolysis in broilers reared under hot conditions. A total of 192 male Ross 308 broilers were distributed in a randomized complete block comprising 3 groups: T- (negative control, no composition according to the invention), B1 (T- + 750 g / ton of composition according to the invention). invention) and B2 (T + 1300 g / ton of composition according to the invention), each repeated 16 times with 4 birds per cage. From day 21 to day 35, the temperature was changed daily to simulate high summer temperatures of up to 30 ° C. Growth performance was measured throughout the experiment. At 36 days, the birds were slaughtered. Plasma markers of oxidative stress, as well as blood hemolysis status, were compared between T- and B2. Water loss and yield nets were compared. The data were analyzed using univariate analysis of variance and Tukey's test as a post-hoc test. The composition according to the invention tested in B1 and B2 had a significant effect on body weight gain, consumption and feed efficiency between 0 and 36 days (P <0.05). A post hoc analysis revealed that B1 gave the best results for the above parameters (P <0.05). The net yield was significantly increased by supplementation via the composition according to the invention, and even more so for B1 (P <0.01). Markers of oxidative stress were not significantly affected by dietary intervention. In addition, B2 had a hemolysis score lower than that of T- (4.12 g / L vs. 4.44 g / L, p <0.05). These results indicate that the composition according to the invention has a positive effect on the growth performance and the integrity of the erythrocytes of broilers, showing better resistance when the thermal environment exceeds the thermoneutrality zone of the animals.

Dans cet exemple, on entend par « composition selon l’invention » :In this example, the term "composition according to the invention" means:

50% d’huile de palme hydrogénée,50% hydrogenated palm oil,

10,4% de silice,10.4% silica,

5% de sulfate de calcium anhydre,5% anhydrous calcium sulphate,

5,3% de vitamine C à 97,5%,5.3% of vitamin C at 97.5%,

0,8% d’extrait de pépins de raisin, 0.8% grape seed extract,

28% de bétaïne anhydre à 96%, et28% betaine anhydrous at 96%, and

0,5% d’un prémélange d’acide folique (0,1% d’acide folique à 92%déposé sur un support, par rapport à la masse totale du prémélange).0.5% of a folic acid premix (0.1% 92% folic acid on a carrier, based on the total weight of the premix).

Exemple 2: Effet de la vectorisation de la bétaïne en conditions de challenge thermique Example 2 Effect of betaine vectorization under thermal challenge conditions

L’objectif de cet essai était de tester une forme vectorisée de bétaïne anhydre de synthèse, en comparaison à une forme de bétaïne anhydre non vectorisée, apportées dans l’aliment de poulets de chair en conditions chaudes, de 21 à 34 jours.The objective of this trial was to test a vectorized form of synthetic anhydrous betaine, compared to a non-vectorized form of anhydrous betaine, made in the broiler feed under hot conditions, from 21 to 34 days.

Les inventeurs ont comparé : The inventors compared:

(1) : Lot témoin négatif sans apport de bétaïne,(1): negative control lot without betaine supply,

(2) : Lot essai avec un apport en bétaïne anhydre de synthèse 96% non vectorisée à 500 ppm,(2): Batch test with betaine anhydrous synthetic 96% not vectorized at 500 ppm,

(3) : Lot essai avec un apport en bétaïne anhydre de synthèse 96% vectorisée à 500 ppm.(3): Batch test with an injection of betaine anhydrous synthesis 96% vectorized at 500 ppm.

Les paramètres suivants ont été relevés :The following parameters have been noted:

performances zootechniques tout au long de l’essai,zootechnical performance throughout the trial,

concentration plasmatique de l’enzyme créatine-kinase (CK) comme indicateur de dommages musculaires liés à une dégradation de la fonction et de la perméabilité membranaire des cellules musculaires, à 34j,Plasma concentration of the creatine kinase enzyme (CK) as an indicator of muscle damage related to a deterioration of the function and membrane permeability of muscle cells, at 34j,

statut antioxydant sanguin via l’activité de l’enzyme Glutathion Peroxydase (GPx), à 34j.blood antioxidant status via the activity of the enzyme Glutathione Peroxidase (GPx), at 34j.

L’essai a été réalisé sur des poulets mâles, souche Ross PM3, répartis dans 20 cages de 4 animaux chacune (soit 6 ou 7 répétitions par groupe).The test was carried out on male chicks, Ross PM3 strain, distributed in 20 cages of 4 animals each (or 6 or 7 repetitions per group).

Le programme thermique suivant a été appliqué à partir de 21 jours d’âge : de 18h à 8h, les poulets sont placés à 24°C, de 8h à 11h à 28°C, de 11h à 15h à 30°C et de 15h à 18h à 28°C.The following thermal program was applied from 21 days of age: from 18h to 8h, the chickens are placed at 24 ° C, from 8h to 11h at 28 ° C, from 11h to 15h at 30 ° C and 15h at 18h at 28 ° C.

RésultatsResults

Maintien de l’intégrité des cellules musculairesMaintaining the integrity of muscle cells  ::

Les résultats sont présentés à la figure 1. L’enzyme plasmatique créatine-kinase est un des indicateurs de dommages musculaires liés à une dégradation de la fonction et de la perméabilité membranaire des cellules musculaires, qui peut se traduire par une dégradation de la qualité de viande.The results are shown in Figure 1 . The plasma creatine kinase enzyme is one of the indicators of muscle damage related to a degradation of the function and membrane permeability of muscle cells, which can result in a degradation of meat quality.

Plus précisément, une myopathie liée à l’hyperthermie est notamment caractérisée par une augmentation de l’activité plasmatique de cette enzyme.More specifically, myopathy related to hyperthermia is characterized in particular by an increase in the plasma activity of this enzyme.

Dans cet essai, l’apport de bétaïne (2) et (3) réduit numériquement le niveau plasmatique de CK par rapport au témoin négatif (1) et la bétaïne vectorisée (3) réduit plus fortement CK (-20% par rapport au témoin négatif) que la bétaïne non vectorisée (2) (-9% par rapport au témoin négatif).In this assay, the betaine supply (2) and (3) numerically reduced the plasma level of CK compared to the negative control (1) and the betaine vectorized (3) reduced more strongly CK (-20% compared to the control negative) that betain non-vectorized (2) (-9% compared to the negative control).

Amélioration du statut oxydatif :Improvement of oxidative status:

Les résultats sont présentés en figure 2. L’augmentation de l’activité de l’enzyme Glutathion Peroxydase (GPx) favorise un système antioxydant stable d’après la littérature.The results are shown in Figure 2 . The increased activity of the enzyme Glutathione Peroxidase (GPx) promotes a stable antioxidant system according to the literature.

L’apport de bétaïne (2) ou (3) augmente numériquement l’activité de l’enzyme GPx par rapport au groupe témoin (1), notamment pour le groupe Bétaïne vectorisée (3) (+12% par rapport au témoin négatif (1) contre 7% pour la Bétaïne non vectorisée (2)).The provision of betaine (2) or (3) numerically increases the activity of the GPx enzyme relative to the control group (1), especially for the betaine-vectorized group (3) (+ 12% compared with the negative control ( 1) versus 7% for non-vectorized Betaine (2)).

Amélioration des performances zootechniques :Improvement of zootechnical performances:

Les résultats sont présentés aux figures 3 et 4. L’apport de bétaïne (2) et (3) a permis d’améliorer l’indice de consommation corrigé du poids par rapport au groupe témoin (1), que ce soit via la forme non vectorisée (2) (-0,03 points) ou la forme vectorisée (3) (-0,05 points). Même observation pour le Gain Moyen Quotidien (GMQ) entre 21 et 34 jours : +3,1% et +3,6% par rapport au groupe témoin respectivement pour le groupe Bétaïne libre 500 ppm (2) et le groupe Bétaïne vectorisée 500 ppm (3).The results are shown in Figures 3 and 4 . Betaine intake (2) and (3) improved the weight-corrected intake index compared with the control group (1), either via the non-vectorized form (2) (-0.03 points) or the vectorized form (3) (-0.05 points). Same observation for the Daily Mean Gain (GMQ) between 21 and 34 days: + 3.1% and + 3.6% compared to the control group respectively for the free Betaine 500 ppm group (2) and the Betaine vectorized group 500 ppm (3).

ConclusionConclusion

Cet essai démontre l’intérêt de la vectorisation de la bétaïne anhydre qui permet d’obtenir de meilleures performances zootechniques par rapport à la bétaïne libre en conditions de challenge thermique, avec une amélioration numérique des marqueurs du stress oxydatifs et de l’intégrité des cellules musculaires.This trial demonstrates the interest of the beta- neability of betaine anhydrous which makes it possible to obtain better zootechnical performances compared to free betaine under conditions of thermal challenge, with a numerical improvement of the oxidative stress markers and the integrity of the cells. muscle.

Exemple 3: Effet de la vectorisation des antioxydants en conditions chaudes Example 3 Effect of Vectorization of Antioxidants in Hot Conditions

L’objectif de cet essai est de comparer les effets de la composition selon l’invention (3) à un apport en antioxydants non vectorisés (2) sur les performances de croissance des volailles de chair, élevées sous des températures tropicales.The objective of this test is to compare the effects of the composition according to the invention (3) with a contribution of non-vectorized antioxidants (2) on the growth performance of meat fowl raised under tropical temperatures.

L’essai a été réalisé en station expérimentale à Dakar au Sénégal, en conditions chaudes (température maximale de 30°C). 810 poulets Cobb500 ont été allotés à 0 jour à raison de 54 poulets par parquets, et 5 parquets par groupe. The test was carried out at an experimental station in Dakar, Senegal, in hot conditions (maximum temperature of 30 ° C). 810 Cobb500 chickens were allotted to 0 days at the rate of 54 chickens per floor, and 5 floors per group.

Les groupes suivants ont été testés :The following groups have been tested:

(1) : Lot témoin négatif sans supplémentation,(1): Negative control lot without supplementation,

(2) : Lot avec apport de vitamine C (5%) et autres antioxydants (vitamines et oligo-éléments) (12%) non vectorisés, mis sur support carbonate de calcium (83%) à 2000 g / tonne d’aliment, de 0 à 42 jours,(2): Batch with vitamin C (5%) and other non-vectorized antioxidants (vitamins and trace elements) (12%), supported on calcium carbonate (83%) at 2000 g / tonne of feed, from 0 to 42 days,

(3) : Lot avec apport de la composition selon l’invention (28% bétaïne anhydre 96%, 5,5% vitamine C, 0,9% autres antioxydants, 15,6% support, 50% matrice cristalline à base d’huile de palme hydrogénée), à 750 g / tonne d’aliment de 0 à 20 jours (phase de démarrage), puis 915 g / tonne d’aliment de 20 à 42 jours (phase de croissance).Ont été relevés pendant toute la durée de l’essai : (3): Batch with addition of the composition according to the invention (28% anhydrous betaine 96%, 5.5% vitamin C, 0.9% other antioxidants, 15.6% carrier, 50% crystalline matrix based on hydrogenated palm oil), at 750 g / ton of food from 0 to 20 days (start-up phase), then 915 g / ton of food from 20 to 42 days (growth phase). duration of the test:

De façon hebdomadaire : les poids individuels, la qualité de la litière et des pattes,Weekly: the individual weights, the quality of the litter and legs,

De façon journalière : la consommation d’aliment et d’eau, la mortalité.On a daily basis: food and water consumption, mortality.

RésultatsResults

Les résultats sont présentés en figures 5 et 6 . The results are presented in Figures 5 and 6 .

L’apport en antioxydants non vectorisés (2) et de la composition selon l’invention (3) chez les poulets de chair élevés dans les conditions d’élevage des zones tropicales, permet d’améliorer significativement les poids des poulets par rapport au témoin négatif (1), respectivement de 5% et 7% à 42 jours.The contribution of non-vectorized antioxidants (2) and of the composition according to the invention (3) in the broiler chickens reared under the conditions of rearing of the tropical zones makes it possible to significantly improve the weights of the chickens compared with the control. negative (1), respectively by 5% and 7% at 42 days.

Cette amélioration du poids des animaux s’explique par une baisse de la consommation d’aliment, d’où une tendance positive sur les indices de consommation (IC en g/g) pour les 2 groupes essai : -2% pour le lot (2) et -5%pour le lot (3).This improvement in the weight of the animals is explained by a drop in feed consumption, hence a positive trend in the consumption indices (IC in g / g) for the 2 test groups: -2% for the batch ( 2) and -5% for lot (3).

Par ailleurs, la viabilité des animaux est améliorée avec l’apport en antioxydants non vectorisés (2) et de la composition selon l’invention (3), puisque la mortalité diminue de respectivement 47 et 52% par rapport au témoin négatif (1).Furthermore, the viability of the animals is improved with the addition of non-vectorized antioxidants (2) and the composition according to the invention (3), since the mortality decreases by 47% and 52% respectively relative to the negative control (1). .

On ne note pas d’effet de la composition selon l’invention (3) sur la qualité des litières et des pattes par rapport au groupe témoin (1).No effect of the composition according to the invention (3) on the quality of the litters and legs compared to the control group (1).

Conclusionsconclusions

Cet essai confirme l’intérêt d’un apport en antioxydants contre les effets du stress thermique chez les volailles de chair, apport qui permet l’amélioration des performances zootechniques (poids à l’abattage, indice de consommation) et l’amélioration de la viabilité des animaux d’élevage.This trial confirms the importance of an antioxidant intake against the effects of heat stress in broiler poultry, a contribution that allows the improvement of zootechnical performances (slaughter weight, consumption index) and the improvement of the viability of farm animals.

Cet effet bénéfique versus stress thermique est d’autant plus important avec la composition selon l’invention (3) dans laquelle les antioxydants sont vectorisés et associés à de la bétaïne, bien que les antioxydants soient apportés en moindre quantité (jusqu’à trois fois moins) par rapport au lot (2) ne comprenant pas de bétaïne,This beneficial effect versus thermal stress is all the more important with the composition according to the invention (3) in which the antioxidants are vectorized and combined with betaine, although the antioxidants are provided in a smaller quantity (up to three times less) than batch (2) not containing betaine,

Exemple 4: Comparaison des effets de la composition selon l’invention à de simples apports en bétaïne libre ou vectorisée, en conditions de challenge thermique Example 4 Comparison of the effects of the composition according to the invention on simple additions of free betaine or vectorized, in conditions of thermal challenge

L’objectif de l’essai est de comparer les effets de la composition selon l’invention (4) en comparaison à un apport de bétaïne libre (2) et de bétaïne vectorisée (3) sur les performances de croissance, les marqueurs du stress oxydatif et la qualité de carcasses de poulets de chair soumis à des températures ambiantes élevées par rapport à la normale saisonnière.The objective of the test is to compare the effects of the composition according to the invention (4) in comparison with a supply of free betaine (2) and betaine vectorized (3) on growth performance, stress markers. oxidation and the quality of broiler carcasses subjected to high ambient temperatures compared to the seasonal norm.

Matériels et méthodesMaterials and methods

L’essai a été réalisé en station expérimentale. Les 256 poulets ont été allotés à 0 jour à raison de 4 poulets mâles Ross 308 par module, répartis en 4 groupes de 16 modules, soit 64 poulets par groupe. The test was carried out in experimental station. The 256 chickens were allotted at 0 days at the rate of 4 Ross 308 male chickens per module, divided into 4 groups of 16 modules, ie 64 chickens per group.

La mise en lot a été réalisée en fonction du poids moyen par module à l'arrivée.Batching was done according to the average weight per module at the finish.

Les groupes suivants ont été testés, sur toute la période de l’essai : The following groups were tested throughout the trial period:

(1) : Lot témoin négatif sans supplémentation en bétaïne ni antioxydant ; (1): Negative control lot without betaine or antioxidant supplementation;

(2) : Lot témoin positif avec bétaïne HCl de synthèse 95% non vectorisée permettant un apport de 700ppm de bétaïne pure ;(2): Positive control lot with betaine HCl synthetic 95% non-vectorized allowing a contribution of 700ppm pure betaine;

(3) : Lot avec apport de bétaïne HCl de synthèse 95% vectorisée avec de l’huile de palme hydrogénée permettant un apport de 350ppm de bétaïne pure ;(3): Batch of betaine synthesis HCl 95% vectorized with hydrogenated palm oil allowing a supply of 350ppm pure betaine;

(4) : Lot avec composition selon l’invention, distribuée à 1500 g / T d’aliment :(4): Lot with composition according to the invention, distributed at 1500 g / T of food:

62,7% d’huile de palme hydrogénée,62.7% hydrogenated palm oil,

15% de silice,15% silica,

5% de sulfate de calcium anhydre,5% anhydrous calcium sulphate,

2,65% de vitamine C à 97,5%,2.65% of vitamin C at 97.5%,

14% de bétaïne anhydre à 96%,14% betaine anhydrous at 96%,

0,4% d’extrait de vitamine E, et0.4% vitamin E extract, and

0,25% d’un prémélange d’acide folique (0,1% d’acide folique à 92% déposé sur un support, par rapport à la masse totale du prémélange)0.25% of a folic acid premix (0.1% 92% folic acid on a carrier, based on the total weight of the premix)

Une période d’adaptation de 20 jours à température standard a d’abord été respectée.An adaptation period of 20 days at standard temperature was first respected.

Puis, à partir de 21 jours d’âge, chaque jour durant l’essai et jusqu’à 36 jours, les poulets ont été soumis au programme thermique suivant : 28°C de 8h à 11h, 30°C de 11h à 15h, 28°C de 15h à 18h, 24°C de 18h à 8h.Then, from 21 days of age, every day during the test and up to 36 days, the chickens were subjected to the following thermal program: 28 ° C from 8h to 11h, 30 ° C from 11h to 15h, 28 ° C from 15h to 18h, 24 ° C from 18h to 8h.

Les animaux ont été abattus à 37 jours d’âge, et la qualité de filet a été relevée.The animals were slaughtered at 37 days of age, and the net quality was raised.

Les performances zootechniques ont été mesurées pendant toute la période de l’essai : poids des animaux, consommation d’aliment, consommation d’eau, notation et matière sèche des fientes, mortalité (nombre, cause).Zootechnical performance was measured throughout the trial period: animal weight, feed consumption, water consumption, scoring and dry matter of droppings, mortality (number, cause).

RésultatsResults

Sur toute la période de l’essai, aucun effet groupe significatif n’est observé sur la mortalité des animaux (p-value = 0.534).Over the entire period of the trial, no significant group effect was observed on animal mortality (p-value = 0.534).

Les résultats sont présentés en figure s 7 et 8 . The results are presented in figure s 7 and 8 .

L’indice de consommation corrigé du poids (ICC) 0-36j est amélioré numériquement par l’apport des 3 solutions (1), (2) et (3) par rapport au témoin négatif (1). The weight-adjusted consumption index (ICC) 0-36j is improved numerically by the addition of the 3 solutions (1), (2) and (3) compared to the negative control (1).

L’apport de 700 ppm de bétaïne sous forme libre (2) et de 350 ppm de bétaïne sous forme vectorisée (3) donne des ICC comparables.The addition of 700 ppm of betaine in free form (2) and 350 ppm of betaine in vectorized form (3) gives comparable ICCs.

L’ICC est significativement amélioré de -0.06 points par rapport au témoin négatif (1) pour le groupe avec la composition selon l’invention (4).The ICC is significantly improved by -0.06 points with respect to the negative control (1) for the group with the composition according to the invention (4).

On observe également un effet groupe significatif sur la variable poids de filets (g) à 37j.There is also a significant group effect on the variable net weight (g) at 37j.

Pas de différence significative en poids de filets pour les groupes (1), (2) et (3).No significant difference in net weight for groups (1), (2) and (3).

Le groupe Composition selon l’invention (4) améliore le poids de filets de +46,8g par rapport au témoin négatif (1).The group Composition according to the invention (4) improves the weight of nets of + 46.8g compared to the negative control (1).

Conclusionsconclusions

Cet essai permet de mettre en évidence l’effet positif de la bétaïne sur les performances des volailles de chair soumis à des températures élevées, avec de la bétaïne vectorisée ou non, et avec la composition selon l’invention.This test makes it possible to demonstrate the positive effect of betaine on the performance of poultry meat subjected to high temperatures, with betaine vectorized or not, and with the composition according to the invention.

La vectorisation de la bétaïne permet d’obtenir des résultats comparables à un apport en bétaïne libre double-dose (3) : 350 ppm vs (2) : 700 ppm.The vectorization of betaine makes it possible to obtain results comparable to a betaine free double-dose (3) dose: 350 ppm vs (2): 700 ppm.

La composition selon l’invention (4), pour une dose équivalence bétaïne moindre (200 ppm), permet d’améliorer encore plus les performances par rapport à un simple apport en bétaïne, vectorisée (3) ou non (2).The composition according to the invention (4), for a lesser betaine equivalent dose (200 ppm), makes it possible to further improve performance with respect to a simple provision of betaine, vectorized (3) or not (2).

Cet essai confirme donc, en condition de stress thermique :This test therefore confirms, under heat stress conditions:

l’intérêt de la vectorisation de la bétaïne démontré au point 2.1 ci-avant,the interest of the betaine vectorization demonstrated in point 2.1 above,

l'intérêt de la bétaïne et des antioxydants apportés via la composition selon l’invention. La composition selon l’invention est le produit qui montre les meilleures performances zootechniques et les meilleures performances d’abattage avec un gain en poids de filets important. the interest of betaine and antioxidants provided via the composition according to the invention. The composition according to the invention is the product which shows the best zootechnical performance and the best slaughtering performance with a significant net weight gain.

D’autres critères de performances telle que la consommation d’eau, la qualité des fientes et la mortalité ne sont pas impactés par l’aliment.Other performance criteria such as water consumption, droppings quality and mortality are not affected by the food.

Exemple 5 : Essai de masse en conditions terrain et en période estivale Example 5 Mass Test in Field and Summer Conditions

L’objectif de cet essai était de tester l’efficacité de la composition selon l’invention, en conditions estivales, sur des poulets de chair entre 29 et 33 jours d’âge.The objective of this test was to test the effectiveness of the composition according to the invention, under summer conditions, on broilers between 29 and 33 days of age.

La composition selon l’invention était incorporée au dernier aliment à 1kg/T et distribuée à 47 000 poulets de chair répartis dans 1 bâtiment témoin (20 000 poulets) et 1 bâtiment essai (27 000 poulets) dans un même élevage, situé dans le nord-ouest de la France, fin août. The composition according to the invention was incorporated into the last food at 1 kg / T and distributed to 47 000 broilers distributed in 1 control building (20 000 chickens) and 1 test building (27 000 chickens) in the same farm, located in the northwestern France, end of August.

Pour cet essai, la composition selon l’invention était constituée de :For this test, the composition according to the invention consisted of:

50% d’huile de palme hydrogénée,50% hydrogenated palm oil,

10,4% de carbonate de calcium,10.4% calcium carbonate,

5% de sulfate de calcium anhydre,5% anhydrous calcium sulphate,

5,3% de vitamine C à 97,5%,5.3% of vitamin C at 97.5%,

28% de bétaïne anhydre à 96%, et28% betaine anhydrous at 96%, and

1,3% de vitamine E1.3% of vitamin E

Les mortalités liées à la chaleur ont été relevées ; les performances zootechniques et les résultats d’abattages ont été mesurés.Heat-related mortalities have been reported; zootechnical performance and slaughter results were measured.

Les animaux du groupe témoin n’ont reçu aucun apport complémentaire à l’aliment habituellement utilisé par l’éleveur. The animals in the control group did not receive any supplement to the feed usually used by the farmer.

Les animaux du groupe essai ont reçu, en plus de l’aliment, la composition selon l’invention, à 1Kg / tonne d’aliment de 29 à 33 jours d’âge. The animals of the test group received, in addition to the food, the composition according to the invention at 1 kg / ton of food of 29 to 33 days of age.

RésultatsResults

Les résultats obtenus sont présentés dans le tableau 1 suivant : Témoin Essai Variation (%) Gain Moyen Quotidien GMQ (g/j) 55,05 56,67 +2,94 I ndice de Consommation 0-3 3 jours 1,63 1,53 -6,13 Mortalité (%) 3,97 1,93 -51,39 The results obtained are presented in the following Table 1: Witness Trial Variation (%) Average Daily Gain GMQ (g / d) 55,05 56.67 2.94 I ndice of Consumption 0-3 3 days 1.63 1.53 -6.13 Mortality (%) 3.97 1.93 -51.39

En moyenne, à 35 jours, on obtient +1,62 g/J de GMQ et -0,10 points d’indice de consommation avec la composition selon l’invention par rapport au témoin négatif. La mortalité (en %) est réduite de 2 points, ce qui représente une diminution de moitié du taux de mortalité.On average, at 35 days, +1.62 g / day of GMQ is obtained and -0.10 points of consumption index with the composition according to the invention compared to the negative control. The mortality (in%) is reduced by 2 points, which represents a halving of the mortality rate.

ConclusionConclusion

Cet essai confirme que l’apport de la composition selon l’invention à 1Kg/T, 5 jours avant abattage, améliore les performances d’élevage (GMQ et efficacité alimentaire) et réduit la mortalité, chez les poulets de chair soumis à des températures estivales. This test confirms that the contribution of the composition according to the invention to 1 kg / T, 5 days before slaughter, improves rearing performance (GMQ and feed efficiency) and reduces mortality, in broilers subjected to temperatures summer.

Claims (10)

Composition comprenant une substance active dispersée dans une matrice, ladite substance active comprenant ou étant essentiellement constituée d’un mélange de bétaïne et d’un agent antioxydant, ledit agent antioxydant étant l’acide ascorbique, ladite matrice étant une matrice cristalline essentiellement constituée d’un ou plusieurs lipides hydrogénés, notamment de l’huile hydrogénée. A composition comprising an active substance dispersed in a matrix, said active substance comprising or consisting essentially of a mixture of betaine and an antioxidant, said antioxidant being ascorbic acid, said matrix being a crystalline matrix consisting essentially of one or more hydrogenated lipids, especially hydrogenated oil. Composition selon la revendication 1, dans laquelle l’acide ascorbique représente de 2,5% à 8% en masse par rapport à la masse totale de la composition.The composition of claim 1, wherein the ascorbic acid is from 2.5% to 8% by weight based on the total weight of the composition. Composition selon la revendication 1 ou la revendication 2, dans laquelle la bétaïne représente de 13% à 40% en masse par rapport à la masse totale de la composition.The composition of claim 1 or claim 2, wherein the betaine is from 13% to 40% by weight based on the total weight of the composition. Composition selon l’une quelconque des revendications 1 à 3, dans laquelle ladite matrice cristalline, constituée d’un ou plusieurs lipides, représente de 25% à 65% en masse par rapport à la masse totale de la composition.Composition according to any one of claims 1 to 3, wherein said crystalline matrix, consisting of one or more lipids, represents from 25% to 65% by weight relative to the total mass of the composition. Composition selon l’une quelconque des revendications 1 à 4, comprenant en outre au moins un agent antioxydant additionnel. The composition of any one of claims 1 to 4, further comprising at least one additional antioxidant. Composition selon la revendication 5, où ledit au moins un agent antioxydant additionnel représente en masse, jusqu’à 2% par rapport à la masse totale de la composition.The composition of claim 5, wherein said at least one additional antioxidant represents by weight, up to 2% based on the total weight of the composition. Composition selon l’une quelconque des revendications 1 à 6, comprenant en outre au moins un support.The composition of any one of claims 1 to 6, further comprising at least one carrier. Aliment destiné à la nutrition des animaux d’élevages comprenant de 0,05% à 0,2% en masse d’une composition telle que définie précédemment par rapport à la masse totale de l’aliment.Feed intended for the nutrition of farm animals comprising from 0.05% to 0.2% by weight of a composition as defined above relative to the total mass of the feed. Procédé de préparation d’une composition selon l’une quelconque des revendications 1 à 7, comprenant les étapes suivantes :
a) la mise en contact d’un ou plusieurs lipides hydrogénés ayant une température de fusion de 55°C à 80°C, notamment de l’huile hydrogénée ayant une température de fusion de 55°C à 80°C, avec de l’acide ascorbique et de la bétaïne, ledit un ou plusieurs lipides hydrogénés étant portés à une température au moins égale à la température de fusion dudit un ou plusieurs lipides hydrogénés de sorte que ce ou ces derniers soient sous forme liquide ou pâteuse,
b) le mélange des composés mis en contact à l’étape précédente, cette étape ayant lieu pendant un intervalle de temps suffisant pour que la température de la mixture issue du dudit mélange homogène redescende à une température inférieure à la température de cristallisation dudit un ou plusieurs lipides hydrogénés pour obtenir une matrice cristalline essentiellement constituée d’un ou plusieurs lipides hydrogénés dans laquelle sont dispersés de l’acide ascorbique et de la bétaïne.
A process for the preparation of a composition according to any one of claims 1 to 7, comprising the following steps:
a) contacting one or more hydrogenated lipids having a melting point of 55 ° C to 80 ° C, especially hydrogenated oil having a melting temperature of 55 ° C to 80 ° C, with ascorbic acid and betaine, said one or more hydrogenated lipids being brought to a temperature at least equal to the melting temperature of said one or more hydrogenated lipids so that they are in liquid or pasty form,
b) the mixture of the compounds contacted in the preceding step, this step taking place during a period of time sufficient for the temperature of the mixture resulting from said homogeneous mixture to drop to a temperature below the crystallization temperature of said one or several hydrogenated lipids to obtain a crystalline matrix consisting essentially of one or more hydrogenated lipids in which are dispersed ascorbic acid and betaine.
Composition telle que définie dans l’une quelconque des revendications 1 à 7, ou aliment selon la revendication 8, pour son utilisation pour la protection contre les effets du stress thermique des animaux monogastriques, notamment les volailles ou les porcins d’élevage.Composition as defined in any one of Claims 1 to 7, or food according to Claim 8, for its use for protection against the effects of heat stress of monogastric animals, in particular farmed poultry or pigs.
PCT/EP2019/053899 2018-02-15 2019-02-15 Anti-stress composition Ceased WO2019158736A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP19706935.4A EP3752010A1 (en) 2018-02-15 2019-02-15 Anti-stress composition

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1851305A FR3077707A1 (en) 2018-02-15 2018-02-15 ANTI-STRESS COMPOSITION
FR18/51305 2018-02-15

Publications (1)

Publication Number Publication Date
WO2019158736A1 true WO2019158736A1 (en) 2019-08-22

Family

ID=65520251

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2019/053899 Ceased WO2019158736A1 (en) 2018-02-15 2019-02-15 Anti-stress composition

Country Status (3)

Country Link
EP (1) EP3752010A1 (en)
FR (2) FR3077707A1 (en)
WO (1) WO2019158736A1 (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10203965A (en) * 1997-01-28 1998-08-04 Takeda Chem Ind Ltd Production of covered preparation
US6485742B1 (en) * 1999-04-05 2002-11-26 Basf Aktiengesellschaft Process for producing coated preparation and its use
WO2004080196A2 (en) * 2003-03-07 2004-09-23 Advanced Bionutrition Corporation Feed formulation for terrestrial and aquatic animals
WO2007075016A1 (en) * 2005-12-29 2007-07-05 Bioleaders Corporation Collagenase inhibitor containing poly-gamma-glutamic acid-vitamin c complex and use thereof
WO2015197714A1 (en) * 2014-06-24 2015-12-30 Dupont Nutrition Biosciences Aps Animal feed and aquafeed
FR3017778B1 (en) 2014-02-25 2017-08-11 Deltavit ADJUVANT COMPRISING BAICALIN PARTICULARLY FROM AN EXTRACT FROM SCUTELLARIA BAICALENSIS AND ANIMAL FEED COMPRISING SUCH AN ADJUVANT

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201411196D0 (en) * 2014-06-24 2014-08-06 Dupont Nutrition Biosci Aps Composition and use thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10203965A (en) * 1997-01-28 1998-08-04 Takeda Chem Ind Ltd Production of covered preparation
US6485742B1 (en) * 1999-04-05 2002-11-26 Basf Aktiengesellschaft Process for producing coated preparation and its use
WO2004080196A2 (en) * 2003-03-07 2004-09-23 Advanced Bionutrition Corporation Feed formulation for terrestrial and aquatic animals
WO2007075016A1 (en) * 2005-12-29 2007-07-05 Bioleaders Corporation Collagenase inhibitor containing poly-gamma-glutamic acid-vitamin c complex and use thereof
FR3017778B1 (en) 2014-02-25 2017-08-11 Deltavit ADJUVANT COMPRISING BAICALIN PARTICULARLY FROM AN EXTRACT FROM SCUTELLARIA BAICALENSIS AND ANIMAL FEED COMPRISING SUCH AN ADJUVANT
WO2015197714A1 (en) * 2014-06-24 2015-12-30 Dupont Nutrition Biosciences Aps Animal feed and aquafeed

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
IFEANYICHUKWU C. EGBUNIWE ET AL: "Behavioral and hematological responses of broiler chickens administered with betaine and ascorbic acid during hot-dry season", JOURNAL OF APPLIED ANIMAL WELFARE SCIENCE, vol. 21, no. 4, 5 February 2018 (2018-02-05), US, pages 334 - 346, XP055585929, ISSN: 1088-8705, DOI: 10.1080/10888705.2018.1426000 *
S KUMAR ET AL: "Effect of ascorbic acid in the drinking water and betaine in the diet on performance, blood haematology, IgG and HSP 70 gene expression in Pekin ducks (ans platyrhynchos domesticus) reared under high temperatures", POULT.SCI, 1 January 2017 (2017-01-01), pages 1612 - 9199, XP055585947, Retrieved from the Internet <URL:https://www.european-poultry-science.com/artikel.dll/EPS-10-1399-eps-2017-177-Kumar_NTk2MjczNA.PDF?UID=D949111677515C67E4FB5C5FE2B63C3ED5F8716FAD9F1D> [retrieved on 20190506], DOI: 10.1399/eps.2017.177 *
YOUSSEF A. ATTIA ET AL: "Laying performance, digestibility and plasma hormones in laying hens exposed to chronic heat stress as affected by betaine, vitamin C, and/or vitamin E supplementation", SPRINGERPLUS, vol. 5, no. 1, 20 September 2016 (2016-09-20), XP055585934, DOI: 10.1186/s40064-016-3304-0 *

Also Published As

Publication number Publication date
EP3752010A1 (en) 2020-12-23
FR3077706A1 (en) 2019-08-16
FR3077706B1 (en) 2023-12-08
FR3077707A1 (en) 2019-08-16

Similar Documents

Publication Publication Date Title
KR102420268B1 (en) Nutritional composition for improving eye health for companion animals
CN102469808B (en) Use of natural substances as feed additives for aquatic animals
US9272009B2 (en) Method for increasing performance of offspring
Helland et al. Atlantic salmon, Salmo salar
Ding et al. Seasonal variations in the fatty acid profile of milk from yaks grazing on the Qinghai-Tibetan plateau
RU2543814C2 (en) Coniferous energy additive
JP2004057156A (en) Fish farm feed
Taher et al. The effect of some food additives on growth parameters of grass carp Ctenopharyngodon idella fingerlings
RU2660264C2 (en) Selection and production of whole algae as a food additive for the large cattle and bisons feeding to produce meat with useful for human health high omega-3 content
Taşkesen et al. Possibilities of using hemp (Cannabis sativa L.) and its byproducts in sheep nutrition—A review
US20110046224A1 (en) Methods to accelerate muscle development, decrease fat deposits, and enhance feeding efficiency in pigs
CN105379966A (en) Water-soluble allicin mixture and preparation method thereof
WO2019158736A1 (en) Anti-stress composition
Hammod et al. The effect of partial replacement of maize by date pits on broiler performance
CA3205146A1 (en) Composition for the nutrition or drink of a non-human animal
WO2022223777A1 (en) Insect fat and uses thereof
JP2011120554A (en) Method for raising pigs, and formula feed for pig-raising
Olowu et al. The Nutritive value and in-vitro digestibility of peels and pomaces of different citrus species: Nutritive value assessment for citrus species by products
Becerra et al. Effect of replacing whole boiled soybeans with duckweed (Lemna sp) in the diets of growing ducks
JPS63237745A (en) Production of animal food with enriched content of alpha-linolenic acid based fatty acid
Bayril et al. Effect of dietary Stevia and ginger extracts on laying performance, fertility, hatchability, and serum biochemical parameters in laying Japanese quails exposed to heat stress.
FR2905827A1 (en) Antioxidant additive, useful to incorporate into food, food complement/food supplement for animal, preferably ruminant, comprises herbal extract e.g. extracts of artichoke, rosemary, tagete, turmeric, citrus fruits, garlic and nettle
Ahmed et al. Sustainable Livestock Farming with Oil Seed Crops and Their By-Products
Pastorelli et al. Opuntia Spp. as Alternative Fodder for Sustainable Livestock Production. Animals 2022, 12, 1597
Nkana Kontchiachou Effects of Cloves (Syzygium aromaticum) Ration Supplementation on Growth Parameters in Guinea Pigs

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19706935

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2019706935

Country of ref document: EP

Effective date: 20200915